Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Lacto-N-difucohexaose II | 62258-12-2 | C38H65NO29 | 999.91 | LNDFH II; Lewis A hexaose |
Lacto-N-neohexaose | 64003-52-7 | C40H68N2O31 | 1072.96 | LNnh; Galb4GlcNAcb3[Galb4GlcNAcb6]Galb4Glc |
Lacto-N-hexaose | 64003-51-6 | C40H68N2O31 | 1072.96 | LNH |
Lacto-N-fucopentaose VI | 145876-86-4 | C32H55NO25 | 853.77 | |
Lacto-N-fucopentaose V | 60254-64-0 | C32H55NO25 | 853.77 | LNFPV; Galb1-3GlcNAcb1-3Galb1-4(Fuca1-3)Glc |
Lacto-N-fucopentaose III | 25541-09-7 | C32H55NO25 H2O | 871.79 | Lewis X antigen; LNFIII; Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc; Lex-lactosel; Lewis-X pentasaccharide |
Lacto-N-fucopentaose I | 7578-25-8 | C32H55NO25 | 853.77 | Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; LNFP I; Blood group O(H) type I determinant |
LACTONE OF CIS JASMONE | 70851-61-5 | C11H18O2 | 182.26 | (Z)-5-Hex-3-enyldihydro-5-methylfuran-2(3H)-one, 2(3H)-Furanone, 5-(3-hexenyl)dihydro-5-methyl-, (Z)-, 2(3H)-Furanone, 5-(3Z)-3-hexenyldihydro-5-methyl-, 4-Methyl-4-hydroxy-cis-7-decenoic acid lactone, LACTONE OF CIS JASMONE |
Lacto-N-difucopentaose I | 221224-60-8 | |||
Lacto-N-difucohexaose I | 16789-38-1 | C38H65NO29 | 999.91 | LNDFH I |
Lacto-N-biose | 50787-09-2 | C14H25NO11 | 383.35 | Gal-b-1,3-GlcNAc; 2-Acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-D-glucopyranose |
Lactonamycin | 182234-02-2 | C28H27NO12 | 569.51 | |
LACTOFERRIN | 146897-68-9 | C141H224N46O29S3 | 3125.8274 | COLOSTRUM; LACTOSIDEROPHILIN (BOVINE); LACTOTRANSFERRIN (BOVINE); LACTOFERRIN, HUMAN; LACTOFERRIN, HUMAN MILK; LACTOFERRIN; LACTOFERRIN (BOVINE); Lactoferricin B |
Lactodifucotetraose | 20768-11-0 | C24H42O19 | 634.58 | LDFT; Difucosyl lactose |
Lactobionic acid | 96-82-2 | C12H22O12 | 358.3 | 4-O-b-D-Galactopyranosyl-D-gluconic acid |
Lactobacillus bulgaricus factor | 496-65-1 | C11H22N2O4S | 278.36838 | (R)-2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethylbutyramide; Lactobacillusbulgaricusfactor; 2,4-dihydroxy-3,3-dimethyl-N-[2-(2-sulfanylethylcarbamoyl)ethyl]butanamide; Pantetheine; pantethine, Bis(N-pantothenylamidoethyl) disulfide |
LACTOBACILLUS ACIDOPHILUS | 308084-36-8 | 0 | LACTOBACILLUS ACIDOPHILUS; Biolact; Biolact (tn); D04349; Lactomin (jan) | |
Lactitol monohydrate | 81025-04-9 | C12H24O11 H2O | 362.33 | 4-O-(b-D-Galactopyranosyl)-D-glucitol monohydrate |
Lactitol anhydrous | 585-86-4 | C12H24O11 | 344.31 | 4-O-b-D-Galactopyranosyl-D-glucitol |
Lactisole sodium | 150436-68-3 | C10H11O4·Na | 218.2 | na-PMP; Sodium 2-(4-methoxyphenoxy)propanoate |
Lactiflorin | 1361049-59-3 | C23H26O10 | 462.45 | |
Lactic anhydride | 97-73-4 | C6H10O5 | 162.1406 | PURASORB(R) DL; TIMTEC-BB SBB008348; TIMTEC-BB SBB007949; DL-DILACTIDE; CIS-(+/-)-3,6-DIMETHYL-1,4-DIOXANE-2,5-DIONE; LACTIC ANHYDRIDE; LACTIDE; LACTIDE(D,L-) |
Lacosamide Impurity 1 | 86921-49-5 | C12H14N2O2 | 218.26 | 2-(Acetylamino)-N-(phenylmethyl)-2-propenamide; 2-Acetamido-N-benzylacrylamide; |
Lacosamide | 175481-36-4 | C13H18N2O3 | 250.3 | ADD 243037; SPM 927; Erlosamide; Harkoseride; (R)-2-acetamido-N-benzyl-3-methoxypropanamide |
Lacinilene C | 41653-72-9 | C15H18O3 | 246.3 | (1R)-1,7-dihydroxy-1,6-dimethyl-4-propan-2-ylnaphthalen-2-one; 1,7-Dihydroxy-1,6-dimethyl-4-isopropylnaphthalen-2(1H)-one |
Laccol | 5862-27-1 | C23H40O2 | 348.57 | 3-Heptadecylcatechol; 3-heptadecylbenzene-1,2-diol |
Lacidipine-d10 | 1185245-62-8 | C26H23NO6D10 | 465.62 | (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester-d10 |
Lacidipine Monomethyl Ester | 103890-81-9 | C25H31NO6 | 441.53 | 4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Ethyl Methyl Ester |
Lacidipine 13C8 | 1261432-01-2 | C13[13C]3H33NO6 | 463.5 | 3,5-diethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-bis(13C)methyl-1,4-dihydro(2,3,5,6-13C4)pyridine-3,5-dicarboxylate |
Lacidipine | 103890-78-4 | C26H33NO6 | 455.54 | GX-1048,GR-43659X,SN-305 |
Lachnone A | 903892-99-9 | C11H10O4 | 206.2 | |
LACCASE | 80498-15-3 | 0 | EC 1.10.3.2; LACC; LACCASE; LACCASE AB; LACCASE, CORIOLUS VERSICOLOR, CLEA; LACCASE, CORIOLUS VERSICOLOR, CROSS-LINKED ENZYME AGGREGATE; LACCASE CV; LACCASE T | |
LACCAIC ACID C | 23241-56-7 | C25H17NO13 | 539.4 | LACCAIC ACID C; LACCAIC ACID C STANDARD; 7-[2-Hydroxy-5-(2-carboxy-2-aminoethyl)phenyl]-3,5,6,8-tetrahydroxy-9,10-dioxo-9,10-dihydro-1,2-anthracenedicarboxylic acid; 7-[5-(2-Amino-2-carboxyethyl)-2-hydroxyphenyl]-9,10-dihydro-3,5,6,8-tetrahydroxy-9,10-dio |
LACCAIC ACID B | 17249-00-2 | C24H16O12 | 496.38 | LACCAIC ACID B; LACCAIC ACID B STANDARD; 7-[2-Hydroxy-5-(2-hydroxyethyl)phenyl]-3,5,6,8-tetrahydroxy-9,10-dioxo-9,10-dihydro-1,2-anthracenedicarboxylic acid; 9,10-Dihydro-3,5,6,8-tetrahydroxy-7-[2-hydroxy-5-(2-hydroxyethyl)phenyl]-9,10-dioxo-1,2-anthracen |
LACCAIC ACID A | 15979-35-8 | C26H19NO12 | 537.43 | LACCAIC ACID A; LACCAIC ACID A STANDARD; 7-[2-Hydroxy-5-[2-(acetylamino)ethyl]phenyl]-3,5,6,8-tetrahydroxy-9,10-dioxo-9,10-dihydro-1,2-anthracenedicarboxylic acid; 7-[5-[2-(Acetylamino)ethyl]-2-hydroxyphenyl]-9,10-dihydro-3,5,6,8-tetrahydroxy-9,10-dioxo-1 |
LABSA | 42615-29-2 | C6H6O3S | 158.175 | LABSA; Linear alkyl benzene sulfonate |
L-Abrine | 526-31-8 | C12H14N2O2 | 218.25 | H-METRP-OH; L-ABRINE; ABRINE; ABRINE, L-; 1-METHYL-L-TRYPTOPHAN; N-METHYLTRYPTOPHAN; N-ME-TRP-OH; N-ME-TRP-OH HCL |
L-[UL-13C6]galactose | 478518-66-0 | 13C6H12O6 | 186.11 | |
Labetalol Impurity C | 30566-92-8 | C23H22N2O3 | 374.44 | 5-(N,N-Dibenzylglycyl)salicylamide |
Labetalol Impurity B HCl (Mixture of Diastereomers) | 33778-93-7 | C20H26ClNO4 | 379.89 | 5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride |
Labetalol Impurity A | 1391051-99-2 | C19H23NO4 | 329.40 | Labetalol-1-carboxylic Acid; Labetalol acid; 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzoic acid |
Labetalol HCl (Mixture of Diastereomers) | 32780-64-6 | C19H25ClN2O3 | 364.87 | labetalol hydrochloride |
Labd-13-ene-8,15-diol | 10267-31-9 | C20H36O2 | 308.5 | (1R,2R,4aS,8aS)-1-((E)-5-hydroxy-3-Methylpent-3-en-1-yl)-2,5,5,8a-tetraMethyldecahydronaphthalen-2-ol |
L-902,688 | 634193-54-7 | C21H27F2N5O2 | 419.5 | (5R)-5-[(E,3R)-4,4-difluoro-3-hydroxy-4-phenylbut-1-enyl]-1-[6-(2H-tetrazol-5-yl)hexyl]pyrrolidin-2-one |
L-869298 | 362718-73-8 | C23H18F8N2O4S | 570.45 | 2-Thiazolemethanol, 5-((1S)-1-(3-(cyclopropyloxy)-4-(difluoromethoxy)phenyl)-2-(1-oxido-3-pyridinyl)ethyl)-alpha,alpha-bis(trifluoromethyl)-; |
L-858,051 hydrochloride | 115116-37-5 | C29H50N2O8·2HCl | 609.6 | [(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] 4-(4-methylpiperazin-1-yl)butanoate dihydrochloride |
L-838,417 | 286456-42-6 | C19H19F2N7O | 399.40 | 3-(2,5-Difluorophenyl)-7-(1,1-dimethylethyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazolo[4,3-b]pyridazine; 5-({[7-tert-butyl-3-(2,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-methyl-1H-1,2,4-triazole; L-838417 |
L-826,266 | 244101-03-9 | C27H21BrClNO4S | 570.9 | (E)-N-(5-Bromo-2-methoxyphenyl)sulfonyl-3-[5-chloro-2-(naphthalen-2-ylmethyl)phenyl]prop-2-enamide |
L-817,818 | 217480-27-8 | C33H36N4O3 | 536.67 | N2-[[2-(2-Naphthalenyl)-1H-benz[g]indol-3-yl]acetyl-D-lysine (2S)-2-aminopropyl ester; L817818; [(2S)-2-aminopropyl] (2S)-6-amino-2-[[2-(2-naphthalen-2-yl-1H-benzo[g]indol-3-yl)acetyl]amino]hexanoate |
L-803,087 trifluoroacetate | 217480-26-7 | C27H30F5N5O5 | 599.56 | N2-[4-(5,7-Difluoro-2-phenyl-1H-indol-3-yl)-1-oxobutyl]-L-arginine methyl ester trifluoroacetate |
L-7-Azatryptophan | 49758-35-2 | C9H12N2O2 | 180.2 | |
L-798,106 | 244101-02-8 | C27H22BrNO4S | 536.44 | N-[(5-Bromo-2-methoxyphenyl)sulfonyl]-3-[2-(2-naphthalenylmethyl)phenyl]-2-propenamide; L-798106; (2E)-N-[(5-Bromo-2-methoxyphenyl)sulfonyl]-3-[2-(2-naphthalenylmethyl)phenyl]-2-propenamide; CM 9; GW 671021; (E)-N-(5-bromo-2-methoxyphenyl)sulfonyl-3-[2-(n |
L791943 | 192767-01-4 | C24H17F10NO4 | 573.38 | 2-[4-[1-[3,4-bis(difluoromethoxy)phenyl]-2-(1-oxidopyridin-1-ium-4-yl)ethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol; L-791,943; L-791943 |
L-779450 | 303727-31-3 | C20H14ClN3O | 347.8 | L-779450; L779450; L 779450; L-779,450; L 779,450; L779,450 |
L-778123 HCl | 253863-00-2 | C22H20ClN5O | 405.88 | 4-((5-((4-(3-chlorophenyl)-3-oxopiperazin-1-yl)methyl)-1H-imidazol-1-yl)methyl)benzonitrile hydrochloride; L778123; L-778123; L 778123; L778,123; L-778,123; L 778,123 HCl |
L-778123 | 183499-57-2 | C22H20ClN5O | 405.886 | L-778,123; L-778,123; L-778,123; L-778123; L 778123; L778123. |
L-771688 | 200050-59-5 | C28H33F2N5O5 | 557.59 | methyl (4S)-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-3-[3-(4-pyridin-2-ylpiperidin-1-yl)propylcarbamoyl]-1,4-dihydropyrimidine; 5-carboxylate; L 771,688; L 771688; L-771,688; L-771688; methyl 4-(3,4-difluorophenyl)-6-((methyloxy)methyl)-2-oxo-3-(((( |
L-768242 | 180002-83-9 | C23H24Cl2N2O3 | 483.82 | GW-405833; (2,3-Dichloro-phenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-yl-ethyl)-indol-1-yl]-methanone; (2,3-dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone; GW405833 |
L-759,633 | 174627-50-0 | C26H40O2 | 384.6 | (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene |
L-755507 | 159182-43-1 | C30H40N4O6S | 584.73 | L-755,507; 1-hexyl-3-[4-[[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]sulfamoyl]phenyl]urea |
L-748,337 | 244192-94-7 | C26H31N3O5S | 497.61 | N-[[3-[(2S)-2-Hydroxy-3-[[2-[4-[(phenylsulfonyl)amino]phenyl]ethyl]amino]propoxy]phenyl]methyl]-acetamide |
L-745,870 trihydrochloride | 866021-03-6 | C18H22N4Cl2 | 436.21 | 3-(4-[4-Chlorophenyl]piperazin-1-yl)-methyl-1H-pyrrolo[2,3-b]pyridine trihydrochloride |
L-744832 | 160141-09-3 | C26H45N3O6S2 | 559.781 | L-744832; L 744832; L744832; L-744,832 |
L-741,742 hydrochloride | 874882-93-6 | C23H26N2Cl2O | 417.38 | 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole hydrochloride |
L-741,626 | 81226-60-0 | C20H21ClN2O | 340.85 | 4-(4-chlorophenyl)-1-(1H-indol-3-ylmethyl)-4-piperidinol; 3-[[4-(4-Chlorophenyl)-4-hydroxypiperidin-l-yl]methyl-1H-indole; 4-(4-chlorophenyl)-1-(1H-indol-3-ylmethyl)piperidin-4-ol; (±)-3-[4-(4-Chlorophenyl)-4-hydroxypiperidinyl]methylindole |
L-733,060 hydrochloride | 148687-76-7 | C20H19F6NO.HCl | 439.82 | L-733,061 hydrochloride; MLS002153399; L-733,060 hydrochloride; (2R,3R)-3-[(3,5-bis(Trifluoromethyl)phenyl)methoxy]-2-phenylpiperidine hydrochloride; SMR001230778 |
L-733,060 | 148700-85-0 | C20H19F6NO | 403.36 | L-733060; L 733060; L 733061; L-733061; L 733,060; L 733,061; (2S,3S)-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine |
L-732,138 | 148451-96-1 | C22H18F6N2O3 | 472.39 | N-Acetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzyl Ester; N-Acetyltryptophan 3,5-bis(trifluoromethyl)benzyl Ester |
L-703,664 succinate | 144776-01-2 | C20H30N4O6S | 454.54 | N,N-Dimethyl-5-[(5-methyl-1,2,5-thiadiazolidin-2-yl)methyl]-S,S-dioxide-1H-indole-3-ethanamine Butanedioate; N,N-Dimethyl-5-[(5-methyl-1,1-dioxido-1,2,5-thiadiazolidin-2-yl)methyl]-1H-indole-3-ethanamine Butanedioate; 1H-Indole-3-ethanamine-1,2,5-thiadiaz |
L-701,324 | 142326-59-8 | C21H14ClNO3 | 363.79 | L-701,324;7-CHLORO-4-HYDROXY-3-(3-PHENOXY)PHENYL-2(1H)-QUINOLINONE;7-CHLORO-4-HYDROXY-3-(3-PHENOXY )PHENYLQUINOLIN-2[1H]-ONE |
L-701,252 | 151057-13-5 | C13H10ClNO3 | 263.68 | 7-Chloro-3-(cyclopropylcarbonyl)-4-hydroxy-2(1H)-quinolinone |
L-694,247 | 137403-12-4 | C20H21N5O3S | 411.48 | N-[4-[[5-[3-(2-aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl]methyl]phenyl]methanesulfonamide; 2-[5-[3-(4-Methylsulfonylamino)benzyl-1,2,4-oxadiazol-5-yl]-1H-indol-3-yl]ethanamine |
L-[UL-13C6]fucose | 478518-52-4 | 13C6H12O5 | 170.11 | 6-deoxy-L-[UL-13C6]galactose |
L-[6-13C]sorbose | 478506-38-6 | 13CC5H12O6 | 181.15 | |
L-[6-13C]idose | 115973-80-3 | 13CC5H12O6 | 181.15 | |
L-[6-13C]fucose | 478518-51-3 | 13CC5H12O5 | 165.15 | 6-deoxy-L-[6-13C]galactose |
L-[6-13C]ascorbic acid | 149153-08-2 | 13CC5H8O6 | 177.12 | [6-13C]vitamin C |
L-[3-13C]fucose | 478518-50-2 | 13CC5H12O5 | 165.15 | 6-deoxy-L-[3-13C]galactose |
L-[5-13C]xylose | 478506-64-8 | 13CC4H10O5 | 151.12 | |
L-[4-13C]sorbose | 478506-34-2 | 13CC5H12O6 | 181.15 | |
L-[3-13C]rhamnose monohydrate | 478511-54-5 | 13CC5H12O5·H2O | 183.16 | 6-deoxy-L-[3-13C]mannose monohydrate |
L-[2-13C]glucose | 478519-05-0 | 13CC5H12O6 | 181.15 | |
L-[2-13C]xylose | 478506-63-7 | 13CC4H10O5 | 151.12 | |
L-[2-13C]rhamnose monohydrate | 478511-51-2 | 13CC5H12O5·H2O | 183.16 | 6-deoxy-L-[2-13C]mannose monohydrate |
L-[1-13C]xylose | 178101-87-6 | 13CC4H10O5 | 151.12 | |
L-[2-13C]fucose | 83379-37-7 | 13CC5H12O5 | 165.15 | 6-deoxy-L-[2-13C]galactose |
L-[2-13C]ascorbic acid | 178101-89-8 | 13CC5H8O6 | 177.12 | [2-13C]vitamin C |
L-[1-13C]rhamnose monohydrate | 478511-48-7 | 13CC5H12O5·H2O | 183.16 | 6-deoxy-L-[1-13C]mannose monohydrate |
L-[1-13C]glucose | 478519-02-7 | 13CC5H12O6 | 181.15 | |
L-(-)-Vesamicol hydrochloride | 112709-59-8 | C17H26ClNO | 295.85 | L-(-)-VESAMICOL HYDROCHLORIDE; 1r-trans-cyclohexano; L(-)-VESAMICOL HCL; L-(-)-2-(4-Phenylpiperidino)cyclohexanol hydrochloride |
L-Threitol | 2319-57-5 | C4H10O4 | 122.12 | 1,3,5-orthoformate-myo-inositol; meso-D-myo-inositol-1,3,5-O-orthoformate; L-1,2,3,4-Butanetetrol; myo-inositol 1,3,5-monoorthoformate; (2s,3s)-butane-1,2,3,4-tetraol |
L-(-)-GLYCERALDEHYDE | 497-09-6 | C3H6O3 | 90.07794;g/mol | L-glyceraldehyde; 497-09-6; L-(-)-Glyceraldehyde; (2S)-2,3-dihydroxypropanal; (S)-2,3-dihydroxypropanal; L-Aldotriose |
L(-)-Camphor | 464-48-2 | C10H16O | 152.23 | (-)-Alcanfor; (1s,4s)-(-)-campho; 7,7-trimethyl-(1s)-bicyclo(2.2.1)heptan-2-on; 7,7-trimethyl-(1s)-bicyclo[2.2.1]heptan-2-on; Camphor, (1S,4S)-(-)-; Camphor, l-, (-)-; CAMPHORE; Levo-(-)-camphor |
L(-)-Alloisothreonine HCl | 955375-67-4 | C4H10ClNO3 | 155.58 | L-ISOTHREONINE HCL |
L(-)-10-Camphorsulfonyl chloride | 39262-22-1 | C10H15ClO3S | 250.74 | L(-)-10-CAMPHORSULFONYL CHLORIDE; (-)-CAMPHOR-10-SULFONYL CHLORIDE; (1R)-(-)-10-CAMPHORSULFONYL CHLORIDE; (1R)-(-)-CAMPHOR-10-SULPHONYL CHLORIDE; (1R)-(-)-CAMPHOR-10-SULFONIC ACID CHLORIDE; (1R)-CAMPHOR-10-SULFONIC ACID CHLORIDE |
Kuwanon H | 76472-87-2 | C45H44O11 | 760.8 | |
L 156602 | 125528-51-5 | C38H64N8O13 | 840.5 | Antibiotic L 16602 |
Kuwanon E | 68401-05-8 | C25H28O6 | 424.5 | (S)-2-[5-[(E)-3,7-Dimethyl-2,6-octadienyl]-2,4-dihydroxyphenyl]-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one;5'-[(E)-3,7-Dimethyl-2,6-octadienyl]-2',4',5,7-tetrahydroxyflavanone |
Kuwanon A | 62949-77-3 | C25H24O6 | 420.45 | 5,7-dihydroxy-2-(5-hydroxy-2,2-dimethylchromen-8-yl)-3-(3-methylbut-2-enyl)chromen-4-one |
Kuwanol C | 123702-94-3 | C25H26O6 | 422.5 | 2-(2,4-dihydroxypheny)-5-hydroxy-8methyl-8-(4-methypent-3-en-1-yl)2H,3H,4H,8H-pyrano[3,2-G]chromen-4-one |
KRP297 | 213252-19-8 | C20H17F3N2O4S | 438.42 | 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide; KCL1998001079; KRP 297; KRP-297; KRP297; L 410198; L-410198; L410198; MK 767; MK-767 |
Kushenol X | 254886-77-6 | C25H28O7 | 440.5 | (2R,3R)-2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-8-(2-isopropenyl-5-methyl-4-hexen-1-yl)-2,3-dihydro-4H-chromen-4-one |
Kushenol W | 254886-76-5 | C21H22O7 | 5,7,2',4'-Tetrahydroxy-5'-methoxy-8-prenylflavanone | |
Kushenol S | 254886-72-1 | C20H20O5 | 5,7,2'-Trihydroxy-8-prenylflavanone | |
Kushenol R | 254886-71-0 | C26H30O5 | (2S)-7,2'-Dihydroxy-8-lavandulyl-5- methoxyflavanone | |
Kushenol Q | 254886-70-9 | C26H32O7 | 5,7,2',4'-Tetrahydroxy-8-[2-(2-hydroxyisopropyl)-5-methyl-4-hexenyl]flavanone | |
Kushenol O | 102390-91-0 | C27H30O13 | Formononetin 7-O-xylosyl-(1->6)-glucoside | |
Kushenol N | 102490-65-3 | C26H30O7 | ||
Kushenol L | 101236-50-4 | C25H28O7 | 440.5 | |
Kushenol K | 101236-49-1 | C26H32O8 | ||
Kushenol I | 99119-69-4 | C26H30O7 | 454.5 | NSC 668937 |
Kushenol A | 99217-63-7 | C25H28O5 | 408.5 | Leachianone E |
Kuromanin chloride | 7084-24-4 | C21H21O11 Cl | 484.85 | Kuromanin chloride |
KURARINONE | 34981-26-5 | C25H28O6 | 2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one | |
Kumbicin C | 1878151-58-6 | C28H24N2O3 | 436.5 | 5,8-di-1H-indol-3-yl-7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-ol |
Kumatakenin | 3301-49-3 | C17H14O6 | 314.3 | 5-hydroxy-2-(4-hydroxyphenyl)-3,7-dimethoxy-1-benzopyran-4-one |
Kulinone | 21688-61-9 | C30H48O2 | 440.7 | |
Kulactone | 22611-36-5 | |||
Kukoamine B | 164991-67-7 | C28H42N4O6 | 530.7 | |
Kukoamine A | 75288-96-9 | C28H42N4O6 | 530.7 | N1,N2-bis(dihydrocaffeoyl)spermine |
Kudinoside D | 173792-61-5 | C47H72O17 | 909.07 | |
KU-60019 | 925701-46-8 | C30H33N3O5S | 547.67 | KU 60019;2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]acetamide;(2R,6S)-rel-2,6-Dimethyl-N-[5-[6-(4-morpholinyl)-4-oxo-4H-pyran-2-yl]-9H-thioxanthen-2-yl]-4-morpholineacetamide |
KU-60019 | 925701-49-1 | C30H33N3O5S | 547.67 | 2-((2S,6R)-2,6-dimethylmorpholino)-N-(5-(6-morpholino-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide; KU60019; KU 60019; KU-60019 |
KU59403 | 845932-30-1 | C29H32N4O4S2 | 564.719 | KU59403 |
KU-55933 | 587871-26-9 | C21H17NO3S2 | 395.49 | KU 55933; KU-55933; KU55933. |
KU-2285 | 121077-11-0 | C8H10F2N4O4 | 264.189 | KU-2285; KU2285; KU 2285. |
KU14R | 189224-48-4 | C13H14N2O | 214.26 | 2-(2-ethyl-3H-1-benzofuran-2-yl)-1H-imidazole 2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazole KU 14R KU-14R KU14R |
Ku-0063794 | 938440-64-3 | C25H31N5O4 | 465.554 | KU0063794; [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol |
KU-0060648 | 881375-00-4 | C33H34N4O4S | 582.71 | |
KU-0058684 | 623578-11-0 | C19H14FN3O3 | 351.337 | KU-0058684; KU0058684; KU 0058684; KU58684; KU 58684; KU-58684 |
KT5823 | 126643-37-6 | C29H25N3O5 | 495.5 | 2,3,9,10,11,12-hexahydro-10R-methoxy-2,9-dimethyl-1-oxo-9S,12R-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, methyl ester; |
KT5720 | 108068-98-0 | C32H31N3O5 | 537 | 2,3,9,10,11,12-hexahydro-10S-hydroxy-9-methyl-1-oxo-9R,12S-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, hexyl ester; KT 5720; KT-5720; KT5720 |
KT5555-Lestaurtinib | 111358-88-4 | C26H21N3O4 | 439.471 | CEP701; KT 5555; Lestaurtinib; SP 924. |
KT203 | 1402612-64-9 | C28H26N4O3 | 466.5 | ML-296; 3-[4-[1-(2-Benzylpiperidine-1-carbonyl)triazol-4-yl]phenyl]benzoic acid |
KT195 | 1402612-58-1 | C27H26N4O2 | 438.5 | ML-295; (4-(4'-Methoxy-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)(2-phenylpiperidin-1-yl)methanone |
KRP-203 | 509088-69-1 | C24H27Cl2NO3S | 480.444 | KRP-203; KRP203; KRP 203. |
KRN7000 | 158021-47-7 | C50H99NO9 | 858.32 | a-Gal-Cer N-[(1S,2S,3R)-1-[(a-D-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide KRN7000 |
KRN633 | 286370-15-8 | C20H21ClN4O4 | 416.86 | KRN633; KRN-633; KRN 633. |
KRN5500 | 151276-95-8 | C28H43N7O7 | 589.694 | KRN5500 |
KRN4884 | 152802-84-1 | C15H14ClN5 | 299.76 | 5-amino-N'-[2-(2-chlorophenyl)ethyl]-N-cyanopyridine-3-carboximidamide; 5-amino-N-(2-(2-chlorophenyl)ethyl)-N'-cyano-3-pyridinecarboxamidine; KRN 4884; KRN-4884; KRN4884 |
KRN383 | 919767-02-5 | C17H17N3O4 | 327.335 | KRN383 |
KRIBB3 | 129414-88-6 | C19H19NO4 | 325.364 | KRIBB3; KRIBB-3; KRIBB 3 |
KRIBB11 | 342639-96-7 | C13H12N6O2 | 284.27 | N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine; KRIBB11; KRIBB-11; KRIBB 11. |
KRH3955 | 1097732-62-1 | C40H63N7O18 | 929.97 | KRH-3955;N1-(4-((((1H-imidazol-2-yl)methyl)((1-methyl-1H-imidazol-2-yl)methyl)amino)methyl)benzyl)-N1-methyl-N4,N4-dipropylbutane-1,4-diamine tris((2R,3R)-2,3-dihydroxysuccinate);2,3-Dihydroxybutanedioic acid N-[[4-[[1H-imidazol-2-ylmethyl-[(1-methylimida |
KRH1636 | 568526-77-2 | C32H37N7O2 | 551.70 | N-[(2S)-5-(diaminomethylideneamino)-1-[[(1S)-1-naphthalen-1-ylethyl]amino]-1-oxopentan-2-yl]-4-[[methyl(pyridin-2-yl)amino]methyl]benzamide;KRH-1636;N-((S)-5-guanidino-1-(((S)-1-(naphthalen-1-yl)ethyl)amino)-1-oxopentan-2-yl)-4-(((pyridin-2-ylmethyl)amino |
KRCA-0008 | 1472795-20-2 | C30H37ClN8O4 | 609.12 | KRCA 0008; KRCA0008 |
KRC-108 | 1146944-35-5 | C20H20N6O | 433.33 | KRC-108; KRC 108; KRC108 |
K-Ras-IN-1 | 84783-01-7 | C11H13NOS | 207.29 | 1-(2-Hydroxythiobenzoyl)pyrrolidine;6-[pyrrolidin-1-yl(sulfanyl)methylidene]cyclohexa-2,4-dien-1-one |
K-Ras(G12C) inhibitor 9 | 1469337-91-4 | C16H21ClIN3O4S | 513.78 | |
Kpt-330, (E)- | 1421923-86-5 | C17H11F6N7O | 443.313 | (E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide; KPT-330, (E)-RN; (E)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide; KPT-330 E-isomer; KPT330 trans isomer; E- |
KOS-1584 | 1032119-44-0 | C27H39NO5S | 489.667 | |
Konjac glucomannan | 37220-17-0 | |||
Kongensin A | 885315-96-8 | C22H30O5 | 374.5 | |
Kojitriose | 74738-47-9 | C18H32O16 | 504.44 | |
Kojitetraose | 112302-52-0 | C24H42O21 | 666.58 | Glca2Glca2Glca2Glc |
Kojipentaose | 112289-20-0 | C30H52O26 | 828.72 | |
Kojic Acid Dipalmitate | 79725-98-7 | C37H64O6 | 604.9 | KAD |
Kojic acid | 501-30-4 | C6H6O4 | 142.11 | 5-hydroxy-2-(hydroxymethyl)pyran-4-one |
Kojibiose | 2140-29-6 | C12H22O11 | 342.30 | 2-O-(a-D-Glucopyranosyl)-a-D-glucopyranose; Glc-a-1,2-Glc |
Kobusone | 24173-71-5 | C14H22O2 | 222.328 | |
Kobusin | 36150-23-9 | C21H22O6 | 370.401 | (+)-Demethoxyaschantin; Demethoxyaschantin; Methylpiperitol; (+)-Spinescin; 5-[(3S,3aR,6S,6aR)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodioxole |
KC7F2 | 927822-86-4 | C16H16Cl4N2O4S4 | 570.38 | |
Kirromycin | 50935-71-2 | C43H60N2O12 | 796.94 | Mocimycin; Delvomycin |
Kirenol | 52659-56-0 | C20H34O4 | 338.5 | (1R,3S,4aS,4bS,7S,10aS)-1,2,3,4,4a,4b,5,6,7,9,10,10a-Dodecahydro-3-hydroxy-7-[(R)-1,2-dihydroxyethyl]-1,4a,7-trimethylphenanthrene-1-methanol;Kirenol; |
KIRA6 | 1589527-65-0 | C28H25F3N6O | 518.53 | 1-[4-(8-amino-3-tert-butylimidazo[1,5-a]pyrazin-1-yl)naphthalen-1-yl]-3-[3-(trifluoromethyl)phenyl]urea; 1-(4-(8-amino-3-(tert-butyl)imidazo[1,5-a]pyrazin-1-yl)naphthalen-1-yl)-3-(3-(trifluoromethyl)phenyl)urea; KIRA analog, 2 |
Kinsenoside | 151870-74-5 | C10H16O8 | 264.2 | (4R)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-one |
Kinetin Riboside | 4338-47-0 | C15H17N5O5 | 347.33 | 6-Furfurylaminopurine Riboside, N6-Furfuryladenosine; N-(2-Furanylmethyl)adenosine; NSC 120958 |
Kinetin | 525-79-1 | C10H9N5O | 215.21 | 6-Furfuryladenine |
Kinetensin (human) | 103131-69-7 | C56H85N17O11 | 1172.39 | Neurotensin-related peptide |
Kinesore | 363571-83-9 | C20H16Br2N4O4 | 536.17 | 3,5-Dibromo-N'-((2,5-dimethyl-1-(3-nitrophenyl)-1H-pyrrol-3-yl)methylene)-4-hydroxybenzohydrazide |
Kinase(phosphorylating), acetate | 9027-42-3 | 0 | EC 2.7.2.1; EC: 2.7.2.1; ATP: ACETATE PHOSPHOTRANSFERASE; ACETATE KINASE; AK; Kinase (phosphorylating), acetate; ACETATE KINASE FROM ESCHERICHIA COLI; ACETATE KINASE FROM BACILLUSSTEAROTHERMO PHILUS | |
KIN59 | 4152-77-6 | C29H26N4O5 | 510.5 | 5'-O-Tritylinosine; 9-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(trityloxymethyl)oxolan-2-yl]-5H-purin-6-one |
KIN1408 | 1903800-11-2 | C25H19F2N3O3S | 479.5 | 7-[[4-(Difluoromethoxy)phenyl]-[(5-methoxy-1,3-benzothiazol-2-yl)amino]methyl]quinolin-8-ol |
KIN1400 | 446826-86-4 | C24H17F2N3O2S | 449.5 | 7-((benzo[d]thiazol-2-ylamino)(4-(difluoromethoxy)phenyl)methyl)quinolin-8-ol |
KIN1148 | 1428729-56-9 | C19H11N3OS2 | 361.44 | N-([1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)naphthalene-2-carboxamide |
Kimcuongin | 1872403-23-0 | C20H20O6 | 356.374 | [1-(7-methoxy-2-oxochromen-8-yl)-3-methyl-1-oxobut-2-en-2-yl] 3-methylbut-2-enoate |
Kijanimicin | 78798-08-0 | C67H100N2O24 | 1317.5 | Sch 25663 |
Kihadanin B | 73793-68-7 | C26H30O9 | 486.517 | |
Kihadanin A | 125276-62-2 | C26H30O9 | 486.517 | Obacunoic acid, 21,23-dihydro-21-hydroxy-23-oxo-, epsilon-lactone |
Kigamicin C | 680571-51-1 | C41H47NO16 | 809.8 | |
kappa-Carrageenan | 11114-20-8 | k-Carrageenan | ||
KDM5-IN-1 | 1628210-26-3 | C17H20N6O | 324.38 | 5-(1-tert-butylpyrazol-4-yl)-7-oxo-6-propan-2-yl-1H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile |
Kifunensine diacetonide | 134234-43-8 | C14H20N2O6 | 312.32 | (3aS,3bR,7aR,11aS,11bR)-Hexahydro-2,2,5,5-tetramethyl-7H-[1,3]dioxino[4,5-e]-1,3-dioxolo[4,5-c]imidazo[1,2-a]pyridine-9,10-dione |
Kif15-IN-2 | 672926-33-9 | C20H20N6O4S | 440.48 | |
Kif15-IN-1 | 672926-32-8 | C20H22N4O5S | 430.48 | |
Kielcorin | 64280-48-4 | C24H20O8 | 436.416 | 2,3-Dihydro-3beta-(4-hydroxy-3-methoxyphenyl)-2alpha-(hydroxymethyl)-5-methoxy-7H-1,4-dioxino[2,3-c]xanthen-7-one |
Kidney Bean Extract | 85085-22-9 | Unspecified | 456.71 | kidney bean extract; Bean, ext.; White Kidney beans P.E; PHASEOLUS LUNATUS (GREEN BEAN) SEED EXTRACT; PHASEOLUS VULGARIS (KIDNEY BEAN) SEED EXTRACT; WhiteKidneyBeanextract; Bean extract; Einecs 285-354-6 |
Ketoconazole-d3 | 1217766-70-5 | C26H25D3Cl2N4O4 | 534.45 | rel-1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone-d3; cis-1-Acetyl-d3-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; (+/- |
Ketoconazole-13C-d3 | 75277-42-1 | C2513CH25D3Cl2N4O4 | 535.45 | |
Ketoconazole N-Oxide | 1392277-16-5 | C26H28Cl2N4O5 | 547.44 | |
Ketoconazole Impurity E | 134071-44-6 | C21H20Cl2N2O5S | 483.37 | cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate; (2R,4R)-rel-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-methanol 4-(4-Methylbenzenesulfonate); |
Ketoconazole Impurity D | 67914-61-8 | C24H26Cl2N4O3 | 489.41 | Deacetyl Ketoconazole; 1-[4-[[(2RS,4SR)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine; cis-1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine |
Kethoxal | 27762-78-3 | C7H12O3 | 148.16 | 3-ethoxy-1,1-dihydroxy-2-butanon; beta-ethoxy-alpha-ketobutyraldehyde; KETHOXAL; 2-KETO-3-ETHOXYBUTYRALDEHYDE; Ketoxal; 3-Ethoxy-1,1-dihydroxy-2-butanone; U-2032 |
Ketene | 463-51-4 | C2H2O | 42.03668 | Carbomethene; ethenone; carbometene; Keten; Ethen-1-one |
Ketazocine | 36292-69-0 | C18H23NO2 | 285.385 | Ketazocine; (-)-Ketocyclazocine |
Ketanserin tartrate | 83846-83-7 | C26H28FN3O9 | 545.52 | 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione (2R,3R)-2,3-dihydroxybutanedioate; Ketanserin (+)-tartrate salt; 3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione (+)-tartrate salt; R 41468 (+)-tartrate |
Ketanserin | 74050-98-9 | C22H22FN3O3 | 395.43 | |
Keratins | 68238-35-7 | 0 | KERATIN; KERATIN, EPIDERMAL; cheratina; detoxin; keratins; keratin from human epidermis; Keratin solution from human epidermis; Keratin, Human Epidermal | |
Keratin hydrolyzed | 69430-36-0 | |||
KERATANASE | 55072-01-0 | 0 | ENDO-BETA-GALACTOSIDASE; EC 3.2.1.103; KERATANASE; KERATANASE, PSEUDOMONAS SPECIES; Endo-b-galactosidase, Escherichia freundii; keratanase from pseudomonas species*10 units per; Keratanase, Pseudomonas sp. *Not for sale in Japan*; KERATANASE FROM PSEUDOMO | |
Keratan sulfate | 9056-36-4 | |||
Keracyanin chloride | 18719-76-1 | C27H31O15·Cl | 631 | Cyanidin 3-rutinoside; Meralop; Sambucin; Antirrhinin; Prunicyanin |
Kenpaullone | 142273-20-9 | C16H11BrN2O | 327.18 | Kenpaullone |
Kendomycin | 183202-73-5 | C29H42O6 | 486.6 | TAN 2162 |
KDM5A-IN-1 | 1905481-36-8 | C15H22N4O2 | 290.36 | N-[(3R)-1-(5-propan-2-yl-1H-pyrazole-3-carbonyl)pyrrolidin-3-yl]cyclopropanecarboxamide KDM5A-IN-1 |
KDM4D-IN-1 | 2098902-68-0 | C11H7N5O | 225.21 | |
KD025 | 911417-87-3 | C26H24N6O2 | 452.518 | SLx-2119; KD-025; 2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide |
KD 5170 | 940943-37-3 | C20H25N3O5S2 | 451.6 | S-(2-(6-(4-(3-(Dimethylamino)propoxy)phenylsulfonamido)pyridin-3-yl)-2-oxoethyl) ethanethioate |
KCN1 | 927823-01-6 | C26H27NO5S | 465.561 | KCN1; KCN-1; KCN 1. |
KCC 07 | 315702-75-1 | C14H11N3OS | 269.32 | 3-[[4-(2-Pyridinyl)-2-thiazolyl]amino]phenol |
KC02 | 1646795-60-9 | C17H21NO3 | 287.4 | 6-(2-Oxo-4-phenethyloxetan-3-ylidene)hexanamide |
KC01 | 1646795-59-6 | C22H39NO3 | 365.6 | (Z)-6-(2-Oxo-4-tridecyloxetan-3-ylidene)hexanamide |
KC 12291 hydrochloride | 181936-98-1 | C22H28N3O3SCl | 449.99 | 3,4-Dimethoxy-N-methyl-N-[3-[(5-phenyl-1,2,4-thiadiazol-3-yl)oxy]propyl]benzeneethanamine hydrochloride |
Kaolin | 100403-46-1 | |||
Kaolin | 68515-07-1 | |||
Kanzonol C | 151135-82-9 | C25H28O4 | 392.49 | 2',4',4-Trihydroxy-3'-prenylchalcone |
Kansuinine A | 57701-86-7 | C37H46O15 | 730.76 | Kansuinin A |
Kanshone H | 1445952-33-9 | C15H20O | 216.324 | (1aR,7R,7aR,7bS)-1,1,7,7a-tetramethyl-1a,6,7,7b-tetrahydrocyclopropa[a]naphthalen-2-one |
Kanshone B | 115370-61-1 | C15H22O4 | 266.337 | (3aR,7R,9R,9aR,9bS)-7-hydroxy-1,1,9,9a-tetramethyl-3a,4,7,8,9,9b-hexahydronaphtho[2,1-c]dioxol-5-one |
Kanshone A | 115356-18-8 | C15H22O2 | 234.33 | (4R,4aR,5R)-4-(2-hydroxypropan-2-yl)-4a,5-dimethyl-4,5,6,7-tetrahydronaphthalen-1-one |
Kanamycin sulfate | 25389-94-0 | C18H38N4O15S | 582.58 | Kanamycin A monosulfate |
Kanamycin sulfate | 70560-51-9 | C18H36N4O11.H2SO4 | 582.58 | KANAMYCIN MONOSULFATE; KANAMYCIN MONOSULFATE SALT; KANAMYCIN MONO SULPHATE; KAMYCIN; KANAMYCIN ACID SULFATE; KANAMYCIN A SULFATE SALT; KANAMYCIN SULFATE SALT; KANAMYCIN SULFATE, STREPTOMYCES KANAMYCETICUS |
kakkalide | 58274-56-9 | C28H32O15 | 608.6 | |
Kajiichigoside F1 | 95298-47-8 | C36H58O10 | 650.85 | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate |
Kaempferol tetraacetate | 16274-11-6 | C23H18O10 | 454.4 | 2-(4-Acetoxyphenyl)-4-oxo-4H-chroMene-3,5,7-triyl triacetate |
Kaempferol 7-O-rhamnoside | 20196-89-8 | C21H20O10 | 432.4 | Kaempferol-7-O-alpha-L-rhamnoside |
Kaempferol 7-O-neohesperidoside | 17353-03-6 | C27H30O15 | 594.52 | Kaempferol-7-O-alpha-L-rhamnoside-D-glucoside |
Kaempferol 5,7,4'-trimethyl ether | 1098-92-6 | C18H16O6 | 328.316 | 4',5,7-Trimethoxyflavonol; 2-(4-Methoxyphenyl)-3-hydroxy-5,7-dimethoxy-4H-1-benzopyran-4-one; |
Kaempferol 3-sophoroside-7-rhamnoside | 93098-79-4 | C33H40O20 | 756.66 | |
Kaempferol 3-sophoroside-7-glucoside | 55136-76-0 | C33H40O21 | 772.66 | Kaempferol 3-O-beta-D-[beta-D-glucopyranosyl-(1->2)-glucopyranoside]-7-O-beta-D-glucopyranoside; Kaempferol 3-O-beta-D-sophoroside 7-O-beta-D-glucopyranoside; Kaempferol 3-O-beta-sophoroside 7-O-beta-glucoside |
Kaempferol 3-O-rutinoside 7-O-glucoside | 34336-18-0 | C33H40O20 | 756.66 | |
Kaempferol 3-O-rhamninoside | 83170-31-4 | C33H40O19 | 740.66 | 3-[(2S,3R,4S,5R,6R)-6-[[(2R,3R,4R,5S,6S)-3,5-dihydroxy-6-methyl-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |
Kaempferol 3-O-gentiobioside | 22149-35-5 | |||
Kaempferol 3-O-(6''-O-acetyl)glucoside-7-O-rhamnoside | 66465-24-5 | C29H32O16 | 636.56 | Kaempferol 3-(6''-acetylglucoside) 7-rhamnoside |
Kaempferol 3-neohesperidoside | 32602-81-6 | C27H30O15 | 594.5 | Kaempferol-3-O-glucorhamnoside |
Kaempferol 3-[2''-(p-coumaroylglucosyl)rhamnoside] | 107190-70-5 | C36H36O17 | 740.66 | |
Kaempferol 3,7-diglucoside | 25615-14-9 | C27H30O16 | 610.52 | Kaempferol 3,7-di-O-glucoside |
Kaempferol 3,7,4'-trimethyl ether | 15486-34-7 | C18H16O6 | 328.3 | 5-hydroxy-3,7-dimethoxy-2-(4-methoxyphenyl)-4-benzopyrone; 5-hydroxy-3,7-dimethoxy-2-(4-methoxyphenyl)chromen-4-one |
Kaempferol 3,4',7-triacetate | 143724-69-0 | C21H16O9 | ||
Kaempferol | 520-18-3 | C15H10O6 | 286.23 | Robigenin; Kaempherol; Kempferol; Populnetin; Rhamnolutein |
iso-Lacto-N-neooctaose | 67319-96-4 | C54H91N3O41 | 1438.30 | |
JWH 133 | 259869-55-1 | C22H32O | 312.49 | (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; 3-(1,1-dimethylbutyl)-6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran |
JWH 015 | 155471-08-2 | C23H21NO | 327.43 | (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone |
JW74 | 863405-60-1 | C24H20N6O2S | 456.5196 | JW74; JW-74; JW 74 |
JW55 | 664993-53-7 | C25H26N2O5 | 434.492 | |
JW 67 | 442644-28-2 | C21H18N2O6 | 394.38 | Trispiro[3H-indole-3,2'-[1,3]dioxane-2'',3'''-[3H]indole]-2,2'''(1H,1'''H)-dione |
JW 642 | 1416133-89-5 | C21H20F6N2O3 | 462.39 | JW-642; JW642 |
JW 618 | 1416133-88-4 | C17H14F6N2O2 | 392.3 | 1,1,1,3,3,3-hexafluoropropan-2-yl N-methyl-N-[(3-pyridin-4-ylphenyl)methyl]carbamate |
JW 480 | 1354359-53-7 | C22H23NO2 | 333.42 | 2-Isopropylphenyl(2-(naphthalen-2-yl)ethyl)carbamate |
Juvenile hormone II | 34218-61-6 | C16H26O3 | 266.38 | TRANS,TRANS-10,11-EPOXY-3,7,11-TRIMETHYL-2,6-DODECADIENIC ACID METHYL ESTER; JH II; JH-III; JUVENILE HORMONE 11; JUVENILE HORMONE III; MANDUCA HORMONE; [+/-]-CIS-10,11-EPOXY-3,7,11-TRIMETHYL-TRANS,TRANS-2,6-DODECADIENOIC ACID METHYL ESTER; C16-JUVENILE HO |
Juniper,Juniperus mexicana, ext. | 91722-61-1 | |||
Junipediol B 8-O-glucoside | 188894-19-1 | C16H22O9 | 358.3 | 2-(1,3-Benzodioxol-5-yl)-3-hydroxypropyl beta-D-glucopyranoside; |
JNJ 303 | 878489-28-2 | C21H29ClN2O4S | 440.98 | 2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide |
JNJ 28871063 hydrochloride | 944342-90-9 | C24H27ClN6O3.HCl | 519.42 | 5E-4-Amino-6-(4-benzyloxy-3-chlorophenylamino)pyrimidine-5-carboxaldehyde N-(2-morpholin-4-ylethyl) oxime hydrochloride |
JNJ 27141491 | 871313-59-6 | C17H15F2N3O3S | 379.38 | 4,4-difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide; maraviroc; Pfizer Brand of maraviroc; Selzentry; UK-427,857; UK-427857 |
JNJ 26854165 dihydrochloride | 881202-16-0 | C21H20N4.2HCl | 401.33 | Serdemetan dihydrochloride; N1-[2-(1H-indol-3-yl)ethyl]-N4-4-pyridinyl-1,4-benzenediamine dihydrochloride |
JFD00244 | 96969-83-4 | C30H26N2O4 | 478.5 | BML-266; 1,4-Bis[(P-hydroxyphenethyl)amino]-anthraquinone |
JHW 007 hydrochloride | 202645-74-7 | C24H29F2NO.HCl | 421.95 | (3-endo)-3-[Bis(4-fluorophenyl)methoxy]-8-butyl-8-azabicyclo[3.2.1]octane hydrochloride |
JM-6 | 1008119-83-2 | C23H26N4O6S2 | 518.60 | JM6;3,4-Dimethoxy-N-[4-(3-nitrophenyl)-5-(1-piperidinylmethyl)-2-thiazolyl]-benzenesulfonamide;2-(3,4-Dimethoxybenzenesulfonylamino)-4-(3-nitrophenyl)-5-(piperidin-1-yl)methylthiazole |
JLK 6 | 62252-26-0 | C10H8ClNO3 | 225.63 | 7-amino-4-chloro-3-methoxyisochromen-1-one; 7-Amino-4-chloro-3-methoxyisocoumarin; jlk6; 62252-26-0; JLK 6; 7-Amino-4-chloro-3-methoxy-isocoumarin; gamma-Secretase Inhibitor XI; 7-amino-4-chloro-3-methoxyisochromen-1-one; AC1L1GQZ; AC1Q3FXG; JLK-6; CHEMBL |
JK-P3 | 942655-44-9 | C18H17N3O3 | 323.352 | 3,4-dimethoxy-N-(5-phenyl-1H-pyrazol-3-yl)benzamide |
JJKK 048 | 1515855-97-6 | C23H22N4O5 | 434.44 | JJKK 048; MolPort-035-941-193; BDBM50065646; AKOS025142062; ZINC103287208; [4-[bis(1,3-benzodioxol-5-yl)methyl]piperidin-1-yl]-(1,2,4-triazol-1-yl)methanone |
JJH260 | 1831135-30-8 | C29H34ClN5O5 | 568.1 | 7-(4-(dimethylamino)benzoyl)-1,3-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl 4-(4-chlorophenethyl)piperidine-1-carboxylate |
JIP-1 (153-163) | 438567-88-5 | C61H104N20O14 | 1341.6 | |
Jionoside B1 | 120406-37-3 | C37H50O20 | 814.78 | |
Jionoside A1 | 120444-60-2 | C36H48O20 | 800.8 | |
Jioglutoside B | 124168-00-9 | C23H34O13 | 518.5 | |
Jingzhaotoxin III | 925463-91-8 | C174H241N47O46S6 | 3919.47 | |
Jinflexin D | 2055155-78-5 | C36H32O3 | 512.648 | |
Jinflexin A | 2055155-75-2 | C19H22O3 | 298.382 | |
JIB-04 | 199596-05-9 | C17H13ClN4 | 308.769 | |
JI-101 | 900573-88-8 | C22H20BrN5O2 | 466.339 | JI-101. |
JHU-16907 | 942063-86-7 | C23H21Cl2N5O2 | 469.354 | 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-N-piperidin-1-ylpyrazole-3-carboxamide |
JH-II-127 | 1700693-08-8 | C19H21ClN6O3 | 416.86 | [4-[[5-chloro-4-(methylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxyphenyl]-morpholin-4-ylmethanone JH-II-127 (4-((5-chloro-4-(methylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxyphenyl)(morpholino)methanone 1700693-08-8 JH-II127 J |
JH295 | 1311143-71-1 | C18H16N4O2 | 320.352 | JH295; JH 295; JH-295 |
JH I | 13804-51-8 | C18H30O3 | 294.43 | 12,14-dihomojuvenate; 2,6-tridecadienoicacid,3,11-dimethyl-10,11-epoxy-7-ethyl-,methylester,(e,e; ay22243; c18-juvenilehormone; cecropiajuvenilehormone; juvenilehormonei; methyl12,14-dihomojuvenate; methyl-12-homojuvenate |
JGB1741 | 1256375-38-8 | C27H24N2O2S | 440.6 | ILS-JGB-1741; N-Benzyl-2-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide |
Jervine | 469-59-0 | C27H39NO3 | 425.6 | Iervin; 11-Ketocyclopamine; Jerwiny; (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3-hydroxy-3',6',10,11b-tetramethylspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one |
Jervine | 460-59-0 | C27H39NO3 | ||
Jedi2 | 651005-90-2 | C10H8O3S | 208.23 | 2-Methyl-5-(2-thienyl)-3-furancarboxylic acid; 2-Methyl-5-(thien-2-yl)-3-furoic acid; 2-methyl-5-thiophen-2-ylfuran-3-carboxylic acid; 2-methyl-5-(thiophen-2-yl)furan-3-carboxylic acid |
JDTic dihydrochloride | 785835-79-2 | C28H41Cl2N3O3 | 538.55 | JDTic (2HCl);(3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide hydrochloride;(R)-7-hydroxy-N-((S)-1-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-y |
Jatrophane 6 | 210108-90-0 | C37H48O14 | 716.769 | [(1R,2R,3aR,4S,5S,6E,9S,10S,11S,13R,13aS)-2,4,9,11,13-pentaacetyloxy-3a,10-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-3,4,5,9,10,11,13,13a-octahydro-1H-cyclopenta[12]annulen-1-yl] benzoate |
Jatrophane 4 | 210108-88-6 | C39H52O14 | 744.8 | 2,5,9,14-Tetraacetoxy-3-benzoyloxy-8,15-dihydroxy-7-isobutyroyloxyjatropha-6(17),11E-diene |
Jatrophane 1 | 210108-85-3 | C36H45NO13 | 684.727 | (1R,2R,3aR,5R,9R,11R,13R,13aS,E)-2,5,8,8-tetramethyl-12-methylene-9-(nicotinoyloxy)-4-oxo-1,2,3,4,5,8,9,10,11,12,13,13a-dodecahydro-3aH-cyclopenta[12]annulene-1,2,3a,11,13-pentayl pentaacetate |
Jasminoside B | 214125-04-9 | C16H26O8 | 346.37 | |
Jasminoside | 82451-18-1 | C26H30O13 | 550.17 | |
JASMINONE B | 51608-18-5 | C10H16O | 152.24 | (E)-2-(Pent-2-enyl)cyclopentan-1-one, 2-(trans-2-Pentenyl)cyclopentanone, Cyclopentanone, 2-(2E)-2-penten-1-yl-, JASMINONE B |
Janelia Fluor 549, SE | 1811539-32-8 | C31H25N3O7 | 551.56 | 3,6-Di-1-azetidinyl-9-[2-carboxy-5-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]xanthylium, inner salt |
Janelia Fluor 585, SE | 1811539-88-4 | C34H27F4N3O6 | 649.6 | 1-[10-[2-Carboxy-5-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]-7-(3,3-difluoro-1-azetidinyl)-9,9-dimethyl-2(9H)-anthracenylidene]-3,3-difluoroazetidinium, inner salt |
JAK3-IN-6 | 1443235-95-7 | C19H18N4O3 | 350.37 | JAK3-IN-2; Ethyl 4-[3-(2-methylprop-2-enoylamino)phenyl]-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate |
JAK2 Inhibitor IV | 1110502-30-1 | C17H20N4O2S | 344.43 | JAK2 inhibitor 13 |
Jaceosidin | 18085-97-7 | C17H14O7 | 330.29 | 5,7-dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-6-methoxy-chromen-4-one |
Jaceidin triacetate | 14397-69-4 | C24H22O11 | 486.43 | 4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-[4-(acetyloxy)-3-methoxyphenyl]-3,6-dimethoxy- |
Jaceidin | 10173-01-0 | C18H16O8 | ||
Jacaric acid | 28872-28-8 | C18H30O2 | 278.4 | 8Z,10E,12Z-Octadecatrienoic Acid |
Jacaranone | 60263-07-2 | C9H10O4 | 182.175 | Jacaramome; Jacaranon; methyl(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate |
Ivermectin monosaccharide | 123997-64-8 | C41H62O11 | 730.9 | Dihydroavermectin B1 monosaccharide, Ivermectin B1 monosaccharide |
J 147 | 1146963-51-0 | C18H17F3N2O2 | 350.33 | N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N-[(E)-(3-methoxyphenyl)methylideneamino]acetamide; J-147; 1146963-51-0; N-(2,4-Dimethylphenyl)-2,2,2-trifluoro-N'-(3-methoxybenzylidene)acetohydrazide; CHEMBL2387144; SCHEMBL12995834; 3752AH; AKOS024458485; CS-3688; |
J 113863 | 353791-85-2 | C30H37Cl2IN2O2 | 655.44 | J 113863; J-113863; J113863; UCB 35625; UCB-35625; UCB35625; 2,7-dichloro-N-[1-(cycloocten-1-ylmethyl)-1-ethylpiperidin-1-ium-4-yl]-9H-xanthene-9-carboxamide; iodide |
Izonsteride | 176975-26-1 | C24H26N2OS2 | 422.62 | Izonsteride; LY-320236; (4AR,10BR)-8-[(4-ETHYL-1,3-BENZOTHIAZOL-2-YL)SULFANYL]-4,10B-DIMETHYL-1H,2H,3H,4H,4AH,5H,6H,10BH-BENZO[F]QUINOLIN-3-ONE |
Ixoroside | 58514-30-0 | C16H24O9 | 360.36 | (1S,4aS,7S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-7-hydroxy-7-methylcyclopenta[c]pyran-4-carboxaldehyde |
ixekizumab | 1143503-69-8 | C6492H10012N1728O2028S46 | 146200 | Taltz |
Ivermectin Impurity K | 74567-01-4 | C48H76O14 | 877.13 | 3,4-Dihydro Ivermectin (Mixture of Diastereomers) ; 5-O-Demethyl-3,4,22,23-tetrahydro-avermectin A1a; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran] Avermectin A1a Deriv. |
Ivermectin Impurity I | 71827-03-7 | C48H74O14 | 875.12 | 5-O-Demethyl-22,23-dihydro-avermectin A1a; 2,23-Dihydroavermectin B1a; Dihydroavermectin B1a; |
Ivabradine Impurity 5 | 85175-59-3 | C15H18ClNO3 | 295.77 | 3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one; 3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one; |
Ivabradine Impurity 19 | 73954-34-4 | C14H21NO5 | 283.33 | N-(2,2-Dimethoxy-ethyl)-2-(3,4-dimethoxy-phenyl)-acetamide |
Ivabradine Impurity 18 | 73344-75-9 | C11H15NO2 | 193.25 | 4,5-Dimethoxy-1-(aminomethyl)benzocyclobutane; 1-(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methanamine; 3,4-Dimethoxy-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine |
Ivabradine Impurity 17 | 866783-13-3 | C12H17NO2 | 207.27 | (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane; (7S)-3,4-Dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine |
Ivabradine Impurity 12 HCl | 85175-52-6 | C16H25ClN2O3 | 328.84 | 7,8-Dimethoxy-3-(3-methylamino-propyl)-1,3,4,5-tetrahydro-benzo[d]azepin-2-one HCl |
Ivabradine Impurity 11 | 1132667-04-9 | C12H17NO2 | 207.27 | (7R)-3,4-Dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine |
Ivabradine Impurity 1 | 1462470-54-7 | C27H38N2O6 | 486.61 | [2-(2-{3-[(3,4-Dimethoxy-bicyclo[4.2.0]octa-1(6),2,4-trien-7-ylmethyl)-methyl-amino]-propylamino}-ethyl)-4,5-dimethoxy-phenyl]-acetic acid |
Ivabradine HCl | 148849-67-6 | C27H36N2O5.HCl | 505.05 | S 16257-2 |
Ivabradin D3 HCl | 1217809-61-4 | C27H34D3ClN2O5 | 508.06 | 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino-d3]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one Hydrochloride; |
IU1-47 | 670270-31-2 | C19H23ClN2O | 330.85 | 1-[1-(4-Chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-piperidinyl)ethanone |
IU1 | 314245-33-5 | C18H21FN2O | 300.37 | IU1 |
Itraconazole-d3 | 1217512-35-0 | C35H35D3Cl2N8O4 | 708.67 | (+/-)-4-[4-[4-[4-[[(2R,4S)-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methyl-d3-propyl)-3H-1,2,4-triazol-3-one |
Itraconazole-d5 | 1217510-38-7 | C35H33D5Cl2N8O4 | 710.66 | (+/-)-4-[4-[4-[4-[[(2R,4S)-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl-d5)-3H-1,2,4-triazol-3-one |
Itraconazole Sulfonate Impurity | 67914-86-7 | C14H15Cl2N3O5S | 408.26 | cis-[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyl Methanesulfonate; (2R,4R)-rel-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol Methanesulfonate; |
Itraconazole N-Formyl-Ethlene Impurity | 1199350-00-9 | C34H36Cl2N8O5 | 707.62 | Itraconazole Desethylene-seco-piperazine Mono-N-formyl Impurity; N-(4-(((2R,4S)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-N-(2-((4-(1-(sec-butyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)phenyl)amino)ethyl)formamide |
Itraconazole Impurity 6 | 154003-23-3 | C20H19N3O5S | 484.36 | Cis-[2-(2,4-Dichlorophenyl)-2-(1h-1,2,4-Triazol-1-Ylmethyl)-1,3-Dioxolan-4-Yl]Methyl-4-Methylbenzenesulphonate |
Itraconazole | 84625-61-6 | C35H38Cl2N8O4 | 705.63 | Oriconazole; Sporanox; 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one |
ITP | 35908-31-7 | C10H15N4O14P3(free acid) | 508.16 (free acid) | Inosine-5'-triphosphate, Sodium salt |
Itopride-D6 HCl | 1346601-02-2 | C20H21D6ClN2O4 | 400.93 | N-[[4-[2-(Dimethylamino-d6)ethoxy]phenyl]methyl]-3,4-dimethoxy Benzamide Hydrochloride |
Itopride N-Oxide | 141996-98-7 | C20H26N2O5 | 374.44 | N-[[4-[2-(Dimethyloxidoamino)ethoxy]phenyl]methyl]-3,4-dimethoxybenzamide; N-[[4-[2-(Dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxybenzamide N-Oxide; |
Itopride HCl | 122892-31-3 | C20H27ClN2O4 | 394.89 | Ganaton; HSR803; HSR 803; HSR-803 |
Itopride | 122898-67-3 | C20H26N2O4 | 358.44 | n-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxy-benzamide; ITOPRIDE; ITOPRIDE HYDROCHLORIDE 98-102%; 2-ETHOXY-5-ETHYL-N-((1-ETHYLPYRROLIDIN-2-YL)METHYL)-6-HYDROXY-3-IODOBENZAMIDE HYDROCHLORIDE; 3,4-Dimethoxy-N-[4-[2-(dimethylamino)ethoxy]benzyl] |
Itol A | 1033747-78-2 | C20H32O6 | 368.5 | 20-Deoxyitol B |
ITK inhibitor | 439574-61-5 | C31H39N5O4S2 | 609.82 | |
ITI214 | 1642303-38-5 | C29H29FN7O5P | 605.56 | ITI 214; ITI-214 |
ITH 12575 | 1802013-08-6 | C18H18ClNOS | 331.86 | 7-Chloro-1,5-dihydro-5-[2-(1-methylethyl)phenyl]-4,1-benzothiazepin-2(3H)-one; ITH-12575; ITH12575 |
ITD-1 | 1099644-42-4 | C27H29NO3 | 415.52 | ITD 1; ethyl 2,7,7-trimethyl-5-oxo-4-(4-phenylphenyl)-1,4,6,8-tetrahydroquinoline-3-carboxylate |
Itacitinib | 1334298-90-6 | C26H23F4N9O | 553.51 | 2-[1-[1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile |
IT1t dihydrochloride | 1092776-63-0 | C21H34N4S2.2HCl | 479.57 | N,N'-Dicyclohexylcarbamimidothioic acid (5,6-dihydro-6,6-dimethylimidazo[2,1-b]thiazol-3-yl)methyl ester dihydrochloride; IT1t; IT1t dihydrochloride |
IT1t | 864677-55-4 | C21H34N4S2 | 406.65 | N,N'-Dicyclohexylcarbamimidothioic Acid (5,6-Dihydro-6,6-dimethylimidazo[2,1-b]thiazol-3-yl)methyl Ester;1092776-63-0 (HCl salt); |
IT 901 | 1584121-99-2 | C17H14N2O4S | 342.37 | 5-[(2,4-Dimethoxy-1-naphthalenyl)methylene]dihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione |
Istradefylline Impurity 2 | 606080-73-3 | C20H24N4O4 | 384.44 | 8-[2-(3,4-Dimethoxy-phenyl)-vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-purine-2,6-dione |
Isradipine lactone | 1076198-34-9 | C18H17N3O5 | 355.35 | 4-(2,1,3-Benzoxadiazol-4-yl)-1,4,5,7-tetrahydro-2-methyl-5-oxo-Furo[3,4-b]pyridine-3-carboxylic Acid 1-Methylethyl Ester; |
Isradipine d6 | 1261398-97-3 | C19H15N3O5D6 | 377.43 | |
Isradipine d3 | 1189959-59-8 | C19H18N3O5D3 | 374.41 | 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl-d3 1-Methylethyl Ester |
Isradipine | 75695-93-1 | C19H21N3O5 | 371.39 | |
Ispronicline | 252870-53-4 | C14H22N2O | 234.33728;g/mol | (E,2S)-N-methyl-5-(5-propan-2-yloxypyridin-3-yl)pent-4-en-2-amine; Ispronicline; UNII-3E05NBH9V5; CHEMBL188462; Ispronicline(INN/USAN); TC-1734 |
Isoxepac | 55453-87-7 | C16H12O4 | 268.26 | Olopatadine USP Related Compound C; HP-549; 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid |
Isoxsuprine hydrochloride | 579-56-6 | C18H23NO3·HCl | 337.8 | Duvadilan; Isolait; Isoxsuprine HCl; 4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol hydrochloride |
Isovouacapenol C | 455255-15-9 | C27H34O5 | 438.56 | 6beta-Benzoyl-7beta-hydroxyvouacapen-5alpha-ol |
Isovitexin 2''-O-arabinoside | 53382-71-1 | C26H28O14 | 564.496 | 6-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |
Isovitexin | 29702-25-8 | C21H20O10 | Apigenin-6-C-glucoside; Homovitexin; Saponaretin | |
Isorhamnetin 3-O-galactoside | 6743-92-6 | |||
Isosorbide 5-Mononitrate | 16051-77-7 | C6H9NO6 | 191.14 | Isosorbide mononitrate |
Isosorbide | 652-67-5 | C6H10O4 | 146.14 | |
Isosinensetin | 17290-70-9 | C20H20O7 | 372.369 | 3',4',5,7,8-Pentamethoxyflavone; 5,7,8,3',4'-Pentamethoxyflavone; 6-Demethoxynobiletin |
Isoproterenol sulfate | 6700-39-6 | 2C11H17NO3.2H2O.H2O4S | 556.63 | 1-(3,4-DIHYDROXYPHENYL)-2-ISOPROPYLAMINOETHANOL HEMISULFATE SALT; (-)-ISOPROTERENOL HEMISULFATE; ISOPROTERENOL SULFATE; ISOPROTERENOL SULFATE DIHYDRATE; ISO PROTERENOL SULPHATE; ISOPRENALINE HEMISULFATE SALT; ISOPRENALINE SULFATE; N-ISOPROPYLNORADRENALINE |
ISOPROTERENOL HYDROCHLORIDE | 949-36-0 | C11H18ClNO3 | 247.72 | asthpul; dl-isadrinehydrochloride; dl-isoprenalinehydrochloride; dl-isopropylnoradrenalinehydrochloride; dl-isopropylnorepinephrinehydrochloride; dl-n-isopropylnoradrenalinehydrochloride; racemicisoprenalinehydrochloride; racemicisoproterenolhydrochloride |
isoproterenol | 7683-59-2 | C11H17NO3 | 211.26 | Isoprenaline; Norisodrine; Novodrin; Isoprenalin; Asiprenol;4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;51-30-9(hydrochloride) |
Isoprostane Related Compound 1 | 155551-84-1 | C8H12O4 | 172.18 | |
isopropylmagnesium chloride solution | 1068-55-9 | C3H7ClMg | 102.846 | chloro(1-methylethyl)-magnesiu; isopropylmagnesiumchloridesolution; I-PROPYLMAGNESIUM CHLORIDE; ISOPROPYLMAGNESIUM CHLORIDE; chloro(1-methylethyl)magnesium; ISOPROPYLMAGNESIUM CHLOR. SOL., ~2.0 M I N DIETHYL ETHER |
Isopropyl 4-Chlorobutyrate | 3153-34-2 | C7H13ClO2 | 164.63 | Vilazodone Related Impurity 12; 4-Chloro-butyric Acid Isopropyl Ester; Isopropyl 4-chlorobutanoate; Methylethyl 4-Chlorobutanoate |
Isokurarinone | 52483-02-0 | C26H30O6 | ||
Isokaempferide | 1592-70-7 | C16H12O6 | 300.3 | Kaempferol 3-O-methyl ether; Kaempferol 3-methyl ether |
Isokadsurenin D | 147976-35-0 | C21H24O5 | 356.412 | (6-exo,7-endo)-7-(3,4-Dimethoxyphenyl)-3-methoxy-6-methyl-5-(2-propenyl)-bicyclo[3.2.1]oct-3-ene-2,8-dione; (1R,5R,6R,7R)-5-allyl-7-(3,4-dimethoxyphenyl)-3-methoxy-6-methylbicyclo[3.2.1]oct-3-ene-2,8-dione |
Isokadsuranin | 82467-52-5 | C23H28O6 | 400.471 | Schizandrin B; Wuweizisu B; Gomisin N; Deoxygomisin A |
Isojasmone | 11050-62-7 | C11H16 O | 164.27 | DIHYDRO ISOJASMONATE; 2-methyl-3-pent-2-enylcyclopent-2-enone; 2-Cyclopenten-1-one, 2-methyl-3-(2-pentenyl)-; 2-Methyl-3-pent-2-enylcyclopent-2-enon; 2-methyl-3-(2-pentenyl)-2-cyclopenten-1-on; 2-methyl-3-(2-pentenyl)-2-Cyclopenten-1-one |
Isojasminin | 135378-08-4 | C26H38O12 | 542.57 | |
Isojacareubin | 50597-93-8 | C18H14O6 | 326.3 | 6,10,11-trihydroxy-3,3-dimethyl-3H,7H-pyrano[2,3-c]xanthen-7-one |
Isoiridogermanal | 86293-25-6 | C30H50O4 | 474.726 | 16-Hydroxyiridal |
Isoindigotin | 476-34-6 | C16H10N2O2 | 262.268 | Isoindigo; (3E)-3-(2-oxo-1H-indol-3-ylidene)-1H-indol-2-one |
Isoimperatorin | 482-45-1 | C16H14O4 | 270.284 | Iso Imperatorin; 4-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one |
Isohyenanchin | 19417-00-6 | C15H20O7 | 312.3 | Dihydro-8-hydroxytutin |
Isohomoarbutin | 25162-30-5 | C13H18O7 | 286.28 | beta-D-Glucopyranoside; 4-hydroxy-2-methylphenyl; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxy-2-methylphenoxy)oxane-3,4,5-triol |
Isogranulatimide | 244148-46-7 | C15H8N4O2 | 276.3 | |
Isogosferol | 53319-52-1 | C16H14O5 | 286.3 | 9-(2-hydroxy-3-methylbut-3-enoxy)-7-furo[3,2-g][1]benzopyranone |
Isogomisin O | 83916-76-1 | C23H28O7 | 416.5 | (6S,7S,8R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrob enzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-8-ol |
Isoginsenoside Rh3 | 166040-90-0 | C36H60O7 | 604.86 | |
Isoginkgetin | 548-19-6 | C32H22O10 | 566.51 | 2-(4-Methoxyphenyl)-5,7-dihydroxy-8-[2-methoxy-5-(4-oxo-5,7-dihydroxy-4H-1-benzopyran-2-yl)phenyl]-4H-1-benzopyran-4-one; |
iso-Geraniol | 5944-20-7 | C10H18O | 154.24932;g/mol | AC1O6VOA; SCHEMBL1300878; SCHEMBL1829279; DTHIOPUFUOMHAY-UXBLZVDNSA-N; 3,7-Dimethyl-3,6-octadiene-1-ol; ZINC15120483 |
Iso-Gatifloxacin | 1029364-65-5 | C19H22FN3O4 | 375.40 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(2-Methyl-1-piperazinyl)-4-oxo-; 4-forMyl-1-(Methoxycarbonyl)-1H-indol-2-ylboronic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(2-Methyl-1-piperazinyl)-4-oxo-3-quinolineca |
Isogarcinol | 71117-97-0 | C38H50O6 | 602.8 | Cambogin |
Isogarciniaxanthone E | 659747-28-1 | C28H32O6 | 464.6 | 1,3,5,6-Tetrahydroxy-4,7,8-triprenylxanthone |
iso-Ganciclovir | 86357-09-7 | C9H13N5O4 | 255.23 | 2-Amino-9-[(2,3-dihydroxypropoxy)methyl]-1,9-dihydro-6H-purin-6-one; Isoganciclovir; (RS)-2-Amino-9-[(2,3-dihydroxypropoxy)methyl]-1,9-dihydro-6H-purin-6-one; Ganciclovir Related Compound A |
Isofutoquinol A | 62499-70-1 | C21H22O5 | 354.40 | |
Isofuranodiene | 57566-47-9 | C15H20O | 216.3 | 8,12-Epoxy-1(10),4,7,11-germacratetraene |
Isofraxidin | 486-21-5 | C11H10O5 | 222.19 | 7-hydroxy-6,8-dimethoxy-2h-1-benzopyran-2-one;7-hydroxy-6,8-dimethoxy-coumari; |
Isoforsythiaside | 1357910-26-9 | C29H36O15 | 624.59 | |
Isofolic acid | 47707-78-8 | C19H19N7O6 | 441.40 | Folic acid impurity C; N-[4-[[(2-Amino-1,4-dihydro-4-oxo-7-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid; Isofolic acid(ep-designation)discontinued |
Isofebrifugine | 32434-44-9 | C16H19N3O3 | 301.3 | |
Isofagomine hydrochloride | 161302-93-8 | C6H13NO3 HCl | 183.63 | (3R,4R,5R)-5-(Hydroxymethyl)piperidine-3,4-diol; 5-Hydroxymethyl-3,4-piperidinediol; Afegostat |
Isofagomine D-Tartrate | 957230-65-8 | C10H19NO9 | 297.26 | (3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol (2S,3S)-2,3-dihydroxysuccinate; AT2101; AT-2101, AT 2101; Isofagomine D-Tartrate; Isofagomine; Afegostat; D-Isofagomine; isoFagomine brand name: Plicera |
Isofagomine | 169105-89-9 | C6H13NO3 | 147.17 | (3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol; Isofagomine; Iso-Fagomine |
ISOEUGENYL PHENYLACETATE | 120-24-1 | C18H18O3 | 282.33 | 2-methoxy-4-prop; 2-methoxy-4-prop-1-enylphenyl; 2-methoxy-4-prop-1-enylphenylphenylacetate; Benzeneaceticacid,2-methoxy-4-(1-propenyl)phenylester; FEMA 2477; ISOEUGENYL PHENYLACETATE; ISOEUGENYL PHENYLACETATE 97+% MIXTURE&; Phenylacetic acid 2-methoxy- |
Isoetarine | 530-08-5 | C13H21NO3 | 239.31 | Dilabron;Etyprenaline;Neoisuprel;WIN-3406;Bronkometer;4-[1-Hydroxy-2-(propan-2-ylamino)butyl]benzene-1,2-diol;Bronkosol;Etyprenalinum |
Isoescin IB | 219944-46-4 | C55H86O24 | 1131.28 | (3beta,4beta,16alpha,21beta,22alpha)-28-(Acetyloxy)-16,22,23-trihydroxy-21-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl O-beta-D-glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-4)]-beta-D-glucopyranosiduronic acid |
Isoescin IA | 219944-39-5 | C55H86O24 | 1131.28 | (3beta,4beta,16alpha,21beta,22alpha)-28-(Acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl O-beta-D-glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-4)]-beta-D-glucopyranosiduronic acid |
Isoerysenegalensein E | 478158-77-9 | C25H26O6 | 422.5 | |
Isoengelitin | 30987-58-7 | C21H22O10 | 434.39 | Isoengeletin |
Isoeleutherin | 1078723-14-4 | C16H16O4 | 272.29 | 1,3-Dimethyl-9-methoxy-3,4-dihydro-1H-naphtho[2,3-c]pyran-5,10-dione |
Isoelemicin | 5273-85-8 | C12H16O3 | 208.3 | 1,2,3-Trimethoxy-5-[(E)-1-propenyl]benzene;1-[(E)-1-Propenyl]-3,4,5-trimethoxybenzene |
Isodunnianol | 139726-30-0 | C27H26O3 | 398.5 | 5,5'-Diallyl-3-(4-allylphenoxy)-2,2'-biphenyldiol |
Isodorsmanin A | 118266-99-2 | C20H20O4 | 324.4 | 1-(3,4-Dihydro-5-hydroxy-2,2-dimethyl-2H-1-benzopyran-8-yl)-3-(4-hydroxyphenyl)-2-propen-1-one |
Isododecane | 7045-71-8 | C12H26 | 170.33 | 2-METHYLHENDECANE; ISODODECANE; undecane,2-methyl-; Isododecane,pract.,85% |
Isodiospyrin | 20175-84-2 | C22H14O6 | 374.4 | 5-hydroxy-6-(4-hydroxy-2-methyl-5,8-dioxo-1-naphthalenyl)-7-methylnaphthalene-1,4-dio ne |
Isodihydrofutoquinol B | 62499-71-2 | C21H24O5 | 356.41 | 4-[2-(1,3-Benzodioxol-5-yl)-1-methylethyl]-4,5-dimethoxy-2-(2-propenyl)-2,5-cyclohexadien-1-one;Lancifolin E |
Isodihydrofutoquinol A | 62560-95-6 | C21H24O5 | 356.41 | Lancifolin F |
Isodictamnine | 484-74-2 | C12H9NO2 | 199.21 | 9-Methylfuro[2,3-b]quinolin-4(9H)-one |
Isoderrone | 121747-89-5 | C20H16O5 | 336.34 | 3-(2,2-Dimethyl-2H-1-benzopyran-6-yl)-5,7-dihydroxy-4H-1-benzopyran-4-one |
Isodeoxyelephantopin | 38927-54-7 | C19H20O6 | 344.36 | (2-cyanophenyl)methyl acetate |
Isodecyl stearate | 31565-38-5 | C28H56O2 | 424.74304 | Isodecylstearate; 8-methylnonyloctadecanoate; 31565-38-5; Octadecanoicacid,isodecylester; Isodecyloctadecanoate; isodecylstearate |
ISOBUTYRALDEHYDE DIETHYL ACETAL | 1741-41-9 | C8H18O2 | 146.23 | ISOBUTYRALDEHYDE DIETHYL ACETAL; 1,1-DIETHOXYISOBUTANE; 1,1-Diethoxy-2-methylpropane; Isobutanal diethyl acetal; Isobutylaldehyde diethyl acetal; Propane, 1,1-diethoxy-2-methyl- |
Irbesartan Related Compound A | 748812-53-5 | C25H30N6O2 | 446.56 | 1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide |
ISC-4 | 1072807-15-8 | C11H13NSe | 238.203 | |
Isavuconazonium sulfate | 946075-13-4 | C35H35F2N8O5S·HO4S | 814.8 | Cresemba |
Isavuconazonium chloride | 338990-84-4 | C35H37Cl3F2N8O5S | 0 | Isavuconazonium chloride |
Isavuconazole-d4 | 1346598-58-0 | C22H13F2N5OSD4 | 441.50 | 4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile-d4; 2R,3R)-3-[4-(4-Cyanophenyl)thiazol-2-yl]-2-(2,5- difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol-d4 |
Isavuconazole | 241479-67-4 | C22H17F2N5OS | 437.47 | BAL4815; BAL-4815; BAL 4815; RO 0094815; RO-0094815; RO0094815; Cresemba |
Isatoribine | 198832-38-1 | C10H14N4O7S | 334.303 | ANA245; Immusine; Isatoribine hydrate; Isatoribine monohydrate; D04619; 7-thia-8-oxoguanosine. |
Isariin | 10409-85-5 | C32H57ON5O7 | 637.85 | Isariin; (R)-N-(N-(N-(N-(N-(3-hydroxy-1-oxododecyl)glycyl)-L-valyl)-D-leucyl)-L-alanyl)-L-Valine rho-lactone, Isariin B, Isariin C, Isariin D, Isarolide |
I-SAP | 133538-58-6 | C22H30INO4S | 531.4 | Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2; (Z)-7-[(1S,2S,3S,5R)-3-[(4-iodophenyl)sulfonylamino]-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid |
Isamoltane hemifumarate | 874882-92-5 | C16H22N2O2.1/2C4H4O4 | 332.4 | 1-[(1-Methylethyl)amino]-3-[2-(1H-pyrrol-1-yl)]-propan-2-ol hemifumarate |
ISAM 140 | 932191-62-3 | C19H19N3O3 | 337.37 | 4-(2-Furanyl)-4,10-dihydro-2-methylpyrimido[1,2-a]benzimidazole-3-carboxylic acid-1-methylethyl ester; (±)-Isopropyl 4-(Furan-2-yl)-2-methyl-1,4-dihydrobenzo-[4,5]imidazo[1,2-a]pyrimidine-3-carboxylate |
ISA-2011B | 1395347-24-6 | C22H18ClN3O4 | 423.85 | (5S,10aS)-5-(5-chloro-1H-indol-3-yl)-9-methyl-8,9,10a,11-tetrahydro-5H-[1,3]dioxolo[4,5-g]pyrazino[1,2-b]isoquinoline-7,10-dione |
Irsogladine Maleate | 84504-69-8 | C13H11Cl2N5O4 | 372.16 | Dicloguamine maleate; MN1695 |
Irsogladine | 57381-26-7 | C9H7Cl2N5 | 256.09 | |
Irosustat | 288628-05-7 | C14H15NO5S | 309.336 | BN83495; BN-83495; STX 64; 667 COUMATE. Irosustat |
Ironpentacarbonyl | 37220-42-1 | Fe(CO)5 | 195.90 | IRON CARBONYL; IRON PENTACARBONYL |
iron-59 | 14596-12-4 | Fe | 58.9349 g/mol | |
Irbesartan N-Trityl Impurity | 886999-35-5 | C44H42N6O | 670.86 | 2-Butyl-3-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one; |
Irbesartan Impurity (Demethyl Irbesartan) | 158778-58-6 | C24H26N6O | 414.51 | 2-Propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one |
Irbesartan impurity | 141745-71-3 | C25H29N3O2 | 403.53 | N-((2'-cyanobiphenyl-4-yl)methyl)-1-pentanamido cyclopentane carboxamide |
Irbesartan dimer impurity | 1346598-52-4 | C39H38N10O | 662.80 | 4'-[2-[1-[(2'-tetrazoylbiphen-4-yl)methyl]-4-oxo-1,3-diazaspiro[4,4]non-2-en-2-yl]pentyl]biphenyl-2-tetrazole; |
Irbesartan D4 | 1216883-23-6 | C25H24D4N6O | 432.55 | 2-Butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one; BMS-186295-d4; SR-47436-d4; Aprovel-d4; Avapro-d4; |
Irbesartan Cyano Impurity | 138401-24-8 | C25H27N3O | 385.51 | 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1'-Biphenyl]-2-carbonitrile; 2-Butyl-3-[[2'-(cyano)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one; |
Irbesartan | 138402-11-6 | C25H28N6O | 428.53 | BMS-186295, SR-47436 |
iralukast | 125617-94-9 | C38H36F3NaO8S | 732.74 | Cgp 45715A;sodium;6-acetyl-3-[(5E,7E,10R)-9-(2-carboxy-4-oxochromen-7-yl)sulfanyl-10-hydroxy-10-[3-(trifluoromethyl)phenyl]deca-5,7-dienoxy]-2-propylphenolate |
IRAK4-IN-3 | 2196204-23-4 | C21H31N5O2 | 385.5 | IRAK4-IN-3 is an IRAK4 inhibitor. |
Irak4-IN-1 | 1820787-94-7 | C19H23N5O | 337.427 | 4-[(4-morpholin-4-ylcyclohexyl)amino]quinazoline-6-carbonitrile |
IRAK-1-4 Inhibitor I | 509093-47-4 | C20H21N5O4 | 395.41 | Benzamide, N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro- |
IRAK inhibitor 6 | 1042672-97-8 | C20H20N4O3S | 396.46 | |
IRAK inhibitor 4 | 1012104-68-5 | C33H35F3N6O3 | 620.66 | |
IRAK inhibitor 3 | 1012343-93-9 | C21H21N5O4S | 439.49 | |
IRAK inhibitor 2 | 928333-30-6 | C17H14N4O2 | 306.32 | Phenol, 4-[6-[(2-furanylmethyl)amino]imidazo[1,2-b]pyridazin-3-yl]- |
IRAK inhibitor 1 | 1042224-63-4 | C17H19N5 | 293.37 | |
IR-825 | 1558079-49-4 | C54H48BrClN2O4 | 823 | |
IR-820 | 172616-80-7 | C46H50ClN2NaO6S2 | 849.48 | New Indocyanine Green; 2-[2-[2-Chloro-3-[[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benzo[e]indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt |
IR-813 perchlorate | 201024-57-9 | C40H40ClN2.ClO4 | 683.66 | 2-[2-[2-chloro-3-[2-(1,3-dihydro-1,1,3-trimethyl-2h-benzo[e]-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1,3-trimethyl-1h-benzo[e]indolium perchlorate; IR-813 perchlorate |
IR-783 | 115970-66-6 | C38H46ClN2NaO6S2 | 749.36 | 2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt |
IR-780 Iodide | 207399-07-3 | C36H44ClIN2 | 667.12 | 2-(2-[2-Chloro-3-[2-(3,3-dimethyl-1-propyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-cyclohex-1-enyl]-vinyl)-3,3-dimethyl-1-propyl-3H-indolium iodide |
IR-746 | 120724-85-8 | C35H43N2NaO6S2 | 674.85 | 2-[7-[1,3-Dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-hepta-1,3,5-trienyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt |
IQ-R | 1345445-57-9 | C34H28N2O7 | 576.60 | IQ-R; IQ-Phodol; CS-4935 |
IQ-1S free acid | 23146-22-7 | C15H9N3O | 247.25 | 11-nitroso-10H-indeno[1,2-b]quinoxaline IQ-1S (free acid) CHEMBL3393601 11-(hydroxyimino)indeno[2,3-b]quinoxaline 11-nitroso-10H-indeno[1,2-b]quinoxaline |
IQ-1 | 331001-62-8 | C21H22N4O2 | 362.42 | 2-(4-Acetyl-phenylazo)-2-(3,3-dimethyl-3,4-dihydro-2H-isoquinolin-1-ylidene)-acetamide |
IQ 3 | 312538-03-7 | C20H11N3O3 | 341.32 | 11H-Indeno[1,2-b]quinoxalin-11-one O-(2-furanylcarbonyl)oxime |
IQ 1S | 1421610-21-0 | C15H8N3NaO | 269.23 | 11H-Indeno[1,2-b]quinoxalin-11-one oxime sodium salt |
Ipsapirone | 95847-70-4 | C19H23N5O3S | 401.48 | TVX Q 7821; 1,1-Dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one; 2-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3(2H)-one-1,1-dioxide |
Iprotiazem | 105118-13-6 | C37H49N3O5S | 647.876 | Iprotiazem; (2R)-2-[2-[[4-[4-[2-(3,4,5-Trimethoxyphenyl)ethyl]piperazin-1-yl]butyl]oxy]phenyl]-4-methyl-2-(1-methylethyl)-2H-1,4-benzothiazin-3(4H)-one; Hoechst-166 |
Iproplatin | 62928-11-4 | C6H22Cl2N2O2Pt | 420.238 | CHIP; Code name: JM-9. |
Ipronidazole-D3 | 1015855-83-0 | 2-Isopropyl-1-methyl-D3- 5-nitro-1H-imidazole | ||
Ipronidazole | 14885-29-1 | 2-Isopropyl-1-methyl-5- nitro-1H-imidazole | ||
Iproniazid-1-oxide | 36781-38-1 | C9H13N3O2 | 195.22 | 4-Pyridinecarboxylic Acid 2-(1-Methylethyl)hydrazide 1-Oxide |
Iproniazid phosphate | 305-33-9 | C9H16N3O5P | 277.21 | phosphoric acid;N'-propan-2-ylpyridine-4-carbohydrazide Iproniazid phosphate 305-33-9 Iproniazide phosphate Marsilid phosphate Isoproniazid phosphate Iproniazid as phosphate N'-Isopropylisonicotinohydrazide phosphate Iproniazid dihydrogen phosphat |
Iprodione-d3 | 36734-19-7 | C13H10Cl2N3O3D3 | 333.19 | 3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide-2,4,6-D3 |
Iprindole | 5560-72-5 | C19H28N2 | 284.439 g/mol | |
Ipriflavone Impurity 1 | 13057-72-2 | C15H10O3 | 238.25 | 7-Hydroxy-3-phenyl-4H-chromen-4-one; 7-Hydroxyisoflavone |
Ipratropium Impurity A | 58005-18-8 | C11H22BrNO | 264.2 | endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide; N-Isopropyltropinium bromide |
Ipratropium bromide monohydrate | 66985-17-9 | C20H30BrNO3·H2O | 430.38 | |
Ipratropium Bromide Impurity F | 17812-46-3 | C20H28BrNO2 | 394.35 | 8-Isopropyl-8-methyl-3-(2-phenyl-acryloyloxy)-8-azonia-bicyclo[3.2.1]octane |
Ipratropium Bromide Impurity E | 183626-76-8 | C19H27NO3 | 317.43 | 3-Hydroxy-2-phenyl-propionic acid 8-isopropyl-8-aza-bicyclo[3.2.1]oct-3-yl ester |
Ipilimumab | 477202-00-9 | C6742H9972N1732O2004S40 | BMS-734016 MDX-010 | |
Ipragliflozin Impurity 1 | 1620758-34-0 | C23H29ClO8 | 468.92 | |
Ipragliflozin | 761423-87-4 | C21H21FO5S | 404.45 | ASP1941; ASP-1941; ASP 1941; Ipragliflozin. Trade name: Suglat. |
iota-Carrageenan | 9062-07-1 | i-Carrageenan | ||
Ipidacrine hydrochloride hydrate | 118499-70-0 | C12H16N2.HCl.H2O | 242.75 | Senita; 2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine hydrochloride hydrate |
Ipidacrine | 62732-44-9 | C12H16N2 | 188.27 | 2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-amine |
IPI-926 Hydrochloride | 1169829-40-6 | C29H49ClN2O3S | 541.23 | N-[(2S,3R,3'R,3aS,4'aR,6S,6'aR,6'bS,7aR,12'aS,12'bS)-2',3',3a,4,4',4'a,5,5',6,6',6'a,6'b,7,7',7a,8',10',12',12'a,12'b-Eicosahydro-3,6,11',12'b-tetramethylspiro[furo[3,2-b]pyridine-2(3H),9'(1'H)-naphth[2,1-a]azulen]-3'-yl]methanesulfonamide Hydrochloride; |
IPI-549 | 1693758-51-8 | C30H24N8O2 | 528.58 | IPI-549; IPI 549; IPI549; SCHEMBL16629991; (S)-2-amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
IPI-3063 | 1425043-73-7 | C25H25N7O2 | 455.51 | 4-Amino-6-[1-[8-(1-methyl-6-oxopyridin-3-yl)-1-oxo-2-propan-2-ylisoquinolin-3-yl]ethylamino]pyrimidine-5-carbonitrile |
Ipfencarbazone | 212201-70-2 | C18H14Cl2F2N4O2 | 427.23 | Ipfencarbazone |
Ipexidine mesylate | 69017-90-9 | C28H62N10O8S2 | 730.98 | 1-[N'-[3-[4-[3-[[amino-(hexylcarbamoylamino)methylidene]amino]propyl]piperazin-1-yl]propyl]carbamimidoyl]-3-hexylurea methanesulfonic acid;Guanidino propyl piperazine;Urea, N,N''-(1,4-Piperazinediylbis(3,1-propanediyliminocarbonimidoyl)bis(N'-hexyl-, dime |
Iperoxo iodide | 247079-84-1 | C10H17N2O2·I | 324.16 | Iperoxo; 4-((4,5-Dihydroisoxazol-3-yl)oxy)-N,N,N-trimethylbut-2-yn-1-aminium iodide |
Ipecoside | 15401-60-2 | C27H35NO12 | 565.57 | |
Ipecac | 8012-96-2 | 0 | SYRUPOFIPECAC; Ipecac extract | |
IPD Hydrochloride | 3458-22-8 | C8H20ClNO6S2 | 325.82 | Yoshi 864; azanediylbis(propane-3,1-diyl) dimethanesulfonate hydrochloride; 3-(3-methylsulfonyloxypropylamino)propyl methanesulfonate;hydrochloride; |
Ipconazole | 125225-28-7 | C18H24ClN3O | 333.861 | IPCONAZOLE; ipconazole (bsi, pa e-iso); knf-317; IPCONAZOLE STANDARD; 2-((4-Chlorophenyl)methyl)-5-(1-methylethyl)-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol; Cyclopentanol, 2-((4-chlorophenyl)methyl)-5-(1-methylethyl)-1-(1H-1,2,4-triazol-1-ylmethyl)-; |
IPC-DHAA | 366793-17-1 | C14H31NO2 | 245.4 | dihexylazanium;acetate;DihexylammoniumAcetate;IPC-DHAA;366793-17-1;ACMC-20al80 |
Ipatasertib HCl | 1489263-16-2 | C24H33Cl2N5O2 | 494.46 | (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one hydrochloride.; GDC0068; GDC-0068; GDC 0068; RG7440; RG-7440; RG 7440; Ipatasertib; Ipatasertib hydrochloride |
Ipatasertib | 1001264-89-6 | C24H32ClN5O2 | 458.0 | GDC-0068; GDC0068; GDC 0068; RG7440; RG-7440; RG 7440; Ipatasertib |
Ipamorelin | 170851-70-4 | C38H49N9O5 | 711.9 | NNC-26-0161; NNC 26-0161; NNC26-0161; NNC-260161; NNC 260161; NNC260161; (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide |
IPAG | 193527-91-2 | C17H22IN3 | 395.29 | 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine |
IPA-3 | 42521-82-4 | C20H14O2S2 | 350.45 | |
IP7e | 500164-74-9 | C23H22N2O4 | 390.43 | 6-[4-[(2-Methoxyethoxy)methyl]phenyl]-5-methyl-3-phenyl-isoxazolo[4,5-c]pyridin-4(5H)-one |
Ip5I | 1294478-76-4 | C20H27N8O24P5 (free acid) | 918.3 (free acid) | P1, P5- Di- (inosine- 5')- pentaphosphate, sodium salt |
IP3/BM | 209479-81-2 | C24H39O27P3 | 852.47 | RAC-MYO-INOSITOL 1,4,5-TRISPHOSPHATE HEXAKIS(ACETOXYMETHYL) ESTER; IP3/BM; IP3/BM RAC-MYO-INOSITOL 1,4,5-TRISPHOSPHATE HEXAKIS(ACETOXYMETHYL) ESTER |
Ioxotrizoic acid | 19863-06-0 | C11H9I3N2O5 | 0 | Ioxotrizoic acid; Ioxotrizoic; 3-(Acetylamino)-5-[(hydroxyacetyl)amino]-2,4,6-triiodobenzoic acid; SH-2.1139/H-248AB |
Ioxaglic acid | 59017-64-0 | C24H21I6N5O8 | 1268.88 g/mol | ioxaglicacid; Ioxaglate; Acidoioxaglico; Acideioxaglique; Acidumioxaglicum; Hexabrix160 |
IOX4 | 1154097-71-8 | C15H16N6O3 | 328.3 | Tert-butyl 6-(5-oxo-4-(1H-1,2,3-triazol-1-yl)-2,5-dihydro-1H-pyrazol-1-yl)nicotinate |
IOX2 | 931398-72-0 | C19H16N2O5 | 352.346 | |
Iosimide | 79211-10-2 | C21H30I3N3O9 | 849.191 g/mol | |
Iopromide Impurity B | 76350-28-2 | C17H22I3N3O7 | 761.09 | Desmethoxy Iopromide; 5-(Acetylamino)-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methyl-1,3-benzene-dicarboxamide; |
Iopromide Impurity A | 122731-59-3 | C15H15I3N2O7 | 716.00 | 3-Amino-5-[[[2,3-bis(acetyloxy)propyl]amino]carbonyl]-2,4,6-triiodo-benzoic Acid |
Iopromide | 73334-07-3 | C18H24I3N3O8 | 791.11 | N,N'-Bis(2,3-Dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-1,3-benzenedicarboxamide; Iopromidum; SHL 414C; Ultravist; Ultravist 300; Ultravist 370; ZK 35760; |
Iopamidol-d3 | 1217831-76-9 | C17H19D3I3N3O8 | 780.1 | N,N'-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl-d3]amino]-2,4,6-triiodo-1,3-benzenedicarboxamide |
Iopamidol Impurity K | 1788899-70-6 | C17H23I2N3O8 | 651.20 | |
Iopamidol Impurity J | 77868-44-1 | C16H20I3N3O7 | 747.07 | |
Iopamidol Impurity E | 60166-92-9 | C19H24I3N3O9 | 819.13 | |
Iopamidol Impurity D | 87932-11-4 | C14H15I3N2O7 | 704.00 | |
Iopamidol Impurity B (Desmethyl Iopamidol) | 77868-41-8 | C16H20I3N3O8 | 763.07 | 5-Amino-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo- 1,3-benzenedicarboxamide; |
Iopamidol Impurity (Desdiiodo Iopamidol) | 1798830-49-5 | C17H24IN3O8 | 525.30 | |
Iopamidol EP Impurity G | 1869069-72-6 | C17H22I3N3O8 | 777.09 | |
Iopamidol EP Impurity F | 1869069-71-5 | C16H20I3N3O6 | 731.07 | (S)-N1-(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triido-N3, N3-dimethylisophthalamide |
Iopamidol EP Impurity C | 87932-07-8 | C16H20I3N3O7 | 747.07 | |
Iopamidol | 60166-93-0 | C17H22I3N3O8 | 777.09 | Iopamiro; Isovue; Iopamiron; Niopam; Gastromiro; SQ-13396; SQ 13396; SQ13396 |
Ionone, methyl- | 1335-46-2 | C14H22 O | 206.32 | 6-methylionone; lrone; methyl-ionon; 1-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-1-PENTEN-3-ONE; 5-(2,6,6-TRIMETHYL-2-CYCLOHEXEN-1-YL)-4-PENTEN-3-ONE; BETA-METHYLIONONE; FEMA 2712; IONONE METHYL |
Ionomycin Calcium Salt | 56092-82-1 | C41H70O9Ca | NO0600000 | |
Ionomycin | 56092-81-0 | C41H72O9 | 709.0 | SQ 23377, EM 94 |
Iomeprol | 78649-41-9 | C17H22I3N3O8 | 777.074 | Iomeprol |
Iohexol-d5 | 928623-33-0 | C19H21I3N3O9D5 | 826.18 | 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide-d5 |
Iohexol Related Compound C | 76820-34-3 | C14H19N3O8 | 357.32 | N1,N3-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide; |
Iohexol | 66108-95-0 | C19H26I3N3O9 | 821.14 | Omnepaque |
Ioglunide | 56562-79-9 | C18H24I3N3O9 | 807.111 g/mol | 3-[acetyl(methyl)amino]-N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2,3,4,5,6-pentahydroxyhexanoylamino)benzamide; Ioglunide; CHEMBL2105031 |
Iofratol | 141660-63-1 | C31H36I6N6O13 | 1462.08 g/mol | Iofratol; 141660-63-1; UNII-016B407G6F; AC1OCF73; SCHEMBL381161; CHEMBL2103969 |
Ioforminol | 1095110-48-7 | C33H40I6N6O15 | 1522.14 | GE-145;GE145;AN-113111;AN113111;5,5'-((2-hydroxypropane-1,3-diyl)bis(formylazanediyl))bis(N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide);5-[[3-[3,5-Bis(2,3-dihydroxypropylcarbamoyl)-N-formyl-2,4,6-triiodoanilino]-2-hydroxypropyl]-formylamino] |
Ioflubenzamide I-131 | 864462-68-0 | C21H25F131IN3O3 | 517.346 | BA-100; MIP-1145; Ioflubenzamide I-131. 131-I-MIP-1145; iodine I-131 MIP-1145; |
iodoxamic acid | 31127-82-9 | C26H26I6N2O10 | 1287.9 | Iodoxamicacid; Endomirabil; Videocolangio; Cholevue; Iodoxamsaeure[German]; BC-17 |
Iodosulfuron-methyl | 185119-76-0 | C14H14IN5O6S | 507.26 | IODOSULFURON-METHYL; 4-Iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoic acid methyl ester; Iodosulfuron; Iodosulfuron [iso] |
iodosilane | 13598-42-0 | H3ISi | 158.014 g/mol | |
Iodopravadoline (AM630) | 164178-33-0 | C23H25IN2O3 | 504.37 | AM630; AM-630; AM 630; iodopravadoline. |
Iodophenpropit dihydrobromide | 145196-87-8 | C15H19IN4S.2HBr | 576.13 | N-[2-(4-Iodophenyl)ethyl]-S-[3-(4(5)-imidazolyl)propyl]isothiourea dihydrobromide; 3-(1H-imidazol-5-yl)propyl N'-[2-(4-iodophenyl)ethyl]carbamimidothioate dihydrobromide |
Inulin | 9005-80-5 | C6nH10n+2O5n+1 | 504.44 | Poly-b-(2-1)-fructofuranose; Polyfructose; a-D-glucopyranosyl-[b-D-fructofuranosyl](n-1)-D-fructofuranosides; GpyFn |
Intiquinatine | 445041-75-8 | C18H14BrNO4 | 388.21 | (R)-2-(4-((7-bromoquinolin-2-yl)oxy)phenoxy)propanoic acid |
Intermedin B | 127214-87-3 | C15H22O2 | 234.339 | (6S)-6-[(1R,5S)-5-hydroxy-4-methylidenecyclohex-2-en-1-yl]-2-methylhept-2-en-4-one |
Ingenol-5,20-acetonide-3-O-angelate | 87980-68-5 | C28H38O6 | 470.60 | (9R,12S,12aS,12bR)-12a-hydroxy-2,2,7,7,9,11-hexamethyl-13-oxo-6,6a,7a,8,9,12,12a,12b-octahydro-4H,7H-6,9a-methanocyclopenta[9,10]cyclopropa[5,6]cyclodeca[1,2-d][1,3;Ingenol 5,20-acetonide 3-angelate;Ingenol 3-angelate 5,20-acetonide |
2'-C-Methyl-6-S-methyl-6-thioinosine | 172722-76-8 | C12H16N4O4S | 312.34 | 9-(2-C-Methyl-beta-D-ribofuranosyl)-6-(methylsulfanyl)-9H-purine |
Isoprinosine | 36703-88-5 | C52H78N10O17 | 1115.249 | Inosine pranobex; Inosiplex; Delimmun; Imunovir |
Inosine oxime | 3414-62-8 | C10H13N5O5 | 283.241 g/mol | |
Inosine 5'-diphosphate trisodium salt | 81012-88-6 | C10H11N4O11P2·3Na | 494.13 | IDP 3Na; Inosine-5'-diphosphoric acid trisodium salt |
INOSINE 3'-MONOPHOSPHATE SODIUM SALT | 97259-68-2 | C10H12N4NaO8P | 370.19 | INOSINE 3'-MONOPHOSPHATE SODIUM SALT; 3'-Inosinic acid, disodium salt; INOSINE 3'-MONOPHOSPHATE SODIUM; Inosine 3'-phosphoric acid disodium salt |
inosine | 58-63-9 | C10H12N4O5 | 268.23 | Inosine; Hypoxanthosine; Ribonosine |
Inolitazone dihydrochloride | 223132-38-5 | C27H28Cl2N4O4S | 575.51 | Efatutazone; CS-7017; RS5444; CS 7017; RS 5444 |
Inolitazone | 223132-37-4 | C27H26N4O4S | 502.58 | PPAR-gamma agonist CS-7017, CS-7017, RS5444. Efatutazone. |
Iniparib | 160003-66-7 | C7H5IN2O3 | 292.032 | BSI-201; NSC-746045; IND-71677. Iniparib |
Inicarone | 39178-37-5 | C17H15NO2 | 265.306 g/mol | Inicarone; UNII-1EVW48QLUN; 39178-37-5; L7035; Inicaronum; Inicarona |
INH6 | 1001753-24-7 | C19H18N2OS | 322.42 | N/A |
INH-13 | 1016971-82-6 | C28H31N7O4 | 529.59 | INH-13; INH 13; INH13. |
INH1 hydrochloride | 1780260-01-6 | C18H16N2OS·HCl | 344.86 | N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamide hydrochloride |
INH1 | 313553-47-8 | C18H16N2OS | 308.40 | IBT 13131 |
Ingliforib | 186392-65-4 | C23H24ClN3O5 | 457.91 | 5-chloro-N-[(2S,3R)-4-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-3-hydroxy-4-oxo-1-phenylbutan-2-yl]-1H-indole-2-carboxamide; 5-Chloro-N-((1S,2R)-3-((3R,4S)-3,4-dihydroxy-1-pyrrolidinyl))-2-hydroxy-3-oxo-1-(phenylmethyl)propyl-1H-indole-2-carboxamide; CP-36 |
Ingenol-3-mebutate | 75567-37-2 | C25H34O6 | 430.53 | PEP005; PEP-005; PEP 005; ingenol-3-angelate, Ingenol mebutate; trade name Picato |
Ingenol mebutate-D5 | 849146-39-0 | C25H29O6D5 | 435.58 | |
Ingenol disoxate | 1383547-60-1 | C28H37NO7 | 499.60 | (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulen-6-yl 3,5-diethylisoxazole-4-carboxylate; LEO43204 |
Ingenol 3-palmitate | 52557-26-3 | C36H58O6 | 586.84 | Ingenol 3-hexadecanoate; Hexadecanoic acid, 1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(e)cyclodecen-6-yl ester, (1aR-(1aalpha,2alpha,5beta,5abeta,6beta,8aalpha,9alpha,1 |
Ingenol 3-Hexanoate | 83036-61-7 | C26H38O6 | 446.58 | |
Ingenol 20-palmitate | 39071-33-5 | C36H58O6 | 586.84 | Euphorbia factor I2; Euphorbia factor L4 |
Ingenol | 30220-46-3 | C20H28O5 | 348.44 | 1A,2,5,5A,6,9,10,10A OCTAHYDRO-5,5A,6-TRIHYDROXY4(HYDROXYMETHYL)1,1,7,9-TETRAMETHYL1H-2,8 AMETHANOCYCLOPENTA[A]CYCLOPROPA[E]CYCLODECEN-11 ONE;1 ALPHA,2,5,5 ALPHA,6,9,10,10 ALPHA-OCTAHYDRO-5,5 ALPHA,6-TRIHYDROXY-4-HYDROXYMETHYL-1,1,7,9-RETRAMETHYL-1H-2,8 A |
Ingavirin | 219694-63-0 | C10H15N3O3 | 225.25 | 4-[2-(1H-Imidazol-4-yl)-ethylcarbamoyl]-butyric acid |
Infliximab | 170277-31-3 | C6428H9912N1694O1987 | 144190.3 | Avakine; CT-P 13; Remicade; Unii-B72hh48flu; Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal ca2 heavy chain), disulfide with human-mouse monoclonal ca2 light chain, dimer |
INF39 | 866028-26-4 | C12H13ClO2 | 224.68 | ethyl 2-[(2-chlorophenyl)methyl]prop-2-enoate; SCHEMBL4697641; Ethyl 2-(2-chlorobenzyl)acrylate |
INF 4E | 88039-46-7 | C12H13ClO3 | 240.68 | Ethyl 2[(2-chlorophenyl)(hydroxy)methyl]acrylate |
Inecalcitol | 163217-09-2 | C26H40O3 | 400.59400 | |
INDY | 1169755-45-6 | C12H13NO2S | 235.3 | (1Z)-1-(3-ethyl-5-hydroxy-1,3-benzothiazol-2-ylidene)propan-2-one |
Indoxacarb Impurity 8 | 177905-10-1 | C9H8F3NO3 | 235.16 | [4-(Trifluoromethoxy)phenyl]carbamic Acid Methyl Ester; |
Indoxacarb Impurity 6 | 144172-24-7 | C11H9ClO4 | 240.64 | 5-Chloro-2-hydroxy-2-methoxycarbonyl-1-indanone |
Indoxacarb Impurity 5 | 144171-39-1 | C20H15ClFN3O5 | 469.81 | Indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid,7-chloro-2,5-dihydro-2-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]-,methyl ester |
Indoxacarb Impurity 3 | 133001-07-7 | C17H13ClFN3O | 329.76 | 4-[[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole |
Indacaterol Impurity 2 | 1026461-20-0 | C22H24N2O3 | 364.45 | R-5-[2-(5-Ethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-3,4-dihydro-1H-quinolin-2-one |
Indacaterol Impurity 1 | 1403389-05-8 | C24H30N2O3 | 394.52 | R-5-[2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-3,4-dihydro-1H-quinolin-2-one |
Indo 1 | 96314-96-4 | C32H26K5N3O12 | 840.05 | 4-(6-CARBOXY-2-INDOLYL)-4'-METHYL-2,2-(ETHYLENEDIOXY)DIANILINE-N,N,N',N'-TETRAACETIC ACID PENTAPOTASSIUM SALT; INDO 1 PENTAPOTASSIUM SALT; INDO 1; INDO 1, FOR FLUORESCENCE; INDO 1 PENTASODIUM SALT >95% FLUORESCENT MARKER FO; 4-(6-carboxy-2-indolyl)-4'-me |
Indium(III) trifluoroacetate | 36554-90-2 | C6F6InO6 | 453.86 | INDIUM(III)TRIFLUOROACETATE; INDIUM TRIFLUOROACETATE; Indium(III)trifluoroacetate,99%; Indium trifluoroacetate 98%; Indiumtrifluoroacetate98%; Trifluoroacetic acid indium salt |
Indium(III) sulfide red | 12030-24-9 | In2S3 | 325.83 | sulfanylidene(sulfanylideneindiganylsulfanyl)indigane; Indium(III)sulfidered; Indium(III)sulfide; 12030-24-9; indiumsesquisulfide; In2S3 |
Indium(III) sulfate hydrate | 13464-82-9 | 517.81 | INDIUM SULFATE; INDIUM SULPHATE; INDIUM(III) SULFATE NONAHYDRATE; INDIUM (III) SULFATE; Diindium tris(sulphate); diindiumtrisulfate; indisulfat; indium(3+)sulfate | |
INDIUM(III) ISOPROPOXIDE, 5 W/V % SOLUTION IN 2-PROPANOL, 99.9+% | 38218-24-5 | C9H21InO3 | 292.07924 | |
Indium(III) iodide | 13510-35-5 | 495.53 | ||
Indium(III) acetate | 25114-58-3 | C2H4InO2 | 291.95 | |
INDIUM TIN OXIDE | 50926-11-9 | In2O5Sn | 428.34 | ITO; INDIUM TIN OXIDE; INDIUM TIN OXIDE COATED PET SHEET, 35 OHM/SQ SURFACE RESISTIVITY (1EA=1FT X 1FT, 5EA = 5 X 1FT X 1FT); Indium tin oxide coated glass slide, 15-25 O/sq surface resistivity; INDIUM TIN OXIDE COATED PET SHEET, 100 OHM/SQ SURFACE RESIST |
INDIUM CHLORIDE, HYDROUS | 143983-91-9 | Cl3H2InO | 239.19 | INDIUM(+3)CHLORIDE HYDRATE; INDIUM CHLORIDE, HYDROUS |
Indium (III) oxide | 1312-43-2 | In2O3 | 277.64 | In2O3; oxo(oxoindiganyloxy)indigane; AC1NP68Z; oxo[(oxoindiganyl)oxy]indigane; 203424_ALDRICH; 289418_ALDRICH |
Indium (II) sulfide (InS, In2S3, 5N, powder & piece) | 12030-14-7 | InS | 146.88 | INDIUM (II) SULFIDE; INDIUM SULFIDE; indium sulphide |
Indisulam | 165668-41-7 | C14H12ClN3O4S2 | 385.837 | E7070; E 7070; E-7070; ER35744; ER 35744; ER-35744; D04522; N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide; 4-N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide |
Indisetron hydrochloride | 160472-97-9 | C17H25Cl2N5O | 386.33 | N-[(1S,5R)-7,9-dimethyl-7,9-diazabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide dihydrochloride |
Indirubin-3'-monoxime | 160807-49-8 | C16H11N3O2 | 277.28 | 3-[3-(hydroxyamino)-1H-indol-2-yl]indol-2-one INDIRUBIN-3'-MONOXIME indirubin-3'-oxime 160807-49-8 indirubin-3-oxime Indirubin-3monoxime indirubin-3'-monooxime 3-[3-(Hydroxyamino)-1H-indol-2-yl]indol-2-one Indirubin-3′-monoxime CHEMBL126077 |
Indirubin | 479-41-4 | C16H10N2O2 | 262.268 | Indigo Red; Indigopurpurin; Couroupitine B; [2,3'-Biindolinylidene]-2',3-dione; 3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one |
Indiplon | 325715-02-4 | C20H16N4O2S | 376.43 | INDIPLON;N-Methyl-N-[3-[3-(thien-2-ylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide;Acetamide, N-methyl-N-(3-(3-(2-thienylcarbonyl)pyrazolo(1,5-A)pyrimidin-7-yl)phenyl)-;NBI 34060;Unii-8bt63da42e |
Indinavir-d6 | 185897-02-3 | C36H41N5O4D6 | 619.84 | 2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl-d6)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide |
Hydroxyethyl starch | 9005-27-0 | (C6H10O5)m(C2H5O)n | ||
Hydroxybutyl methyl cellulose | 9041-56-9 | 1373.6536 | Hydroxybutyl methyl cellulose | |
Hydroxybupropion | 92264-81-8 | C13H18ClNO2 | 255.75 | HYDROXYBUPROPION; HYDROXYBUPROPIONE; 1-(3-CHLOROOPHENYL)-2-[(2-HYDROXY-1,1-DIMETHYLETHYL)AMINO]-1-PROPANONE; 2-HYDROXY-2-(3'-CHLOROPHENYL)-3,5,5-TRIMETHYLMORPHOLINE; 1-(3-Chloroophenyl)-2-[(2-hydroxy-1,1-dimethylethyl)amino]-1-propanone, 2-Hydroxy-2-(3chl |
Hydroxy-beta-sanshool | 97465-69-5 | C16H25NO2 | 263.381 | (2E,6E,8E,10E)-N-(2-hydroxy-2-methylpropyl)dodeca-2,6,8,10-tetraenamide |
HYDROXYAPATITE TYPE I | 130-66-5 | 0 | HYDROXYAPATITE TYPE I | |
Hydroxyapatite | 1306-06-5 | Ca2HO5P | 502.31 | Calcium phosphate hydroxide, Durapatite, Hydroxylapatite |
Humantenirine | 82375-30-2 | C21H26N2O4 | 370.449 | Humantenine, 4-demethyl-11-methoxy-; (3S,3'Z,4'S,4a'S,7'S,9a'S)-3'-ethylidene-1,6-dimethoxy-1',2',3',4',4a',5',9',9a'-octahydro-7'H-spiro[indole-3,8'-[4,7]methanooxepino[4,3-b]pyridin]-2(1H)-one |
Humantenine | 82375-29-9 | C21H26N2O3 | 354.5 | |
Humantenidine | 114027-39-3 | C19H22N2O4 | 342.4 | 14-Hydroxygelsenicine |
HUMANIN TRIFLUOROACETATE | 330936-69-1 | C121H205F3N34O34S2 | 2801.26 | MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA; MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA TRIFLUOROACETATE; MAPRGFSCLLLLTSEIDLPVKRRA; HN; HNMET-ALA-PRO- |
Heptafluoroisopropyl methyl ether | 22052-84-2 | C4H3F7O | 200.05 | HEPTAFLUOROISOPROPYL METHYL ETHER; Perfluoroisopropyl methyl ether |
Heptafluoroisobutyronitrile | 42532-60-5 | C4F7N | 195.0383 | |
Harmalol hydrochloride | 6028-07-5 | C12H13ClN2O | 236.69 | Harmalol HCl |
Harmaline hydrochloride dihydrate | 6027-98-1 | C13H19ClN2O3 | 286.75 | |
Harmalidine | 109794-97-0 | C16H18N2O | 254.333 | Benzo[b]pyrido[2,3,4-gh]pyrrolizine, 1,2,4,5-tetrahydro-8-methoxy-4,4-dimethyl- |
H-Arg-Trp-OH | 25615-38-7 | C17H24N6O3 | 396.87 | H-ARG-TRP-OH HCL; H-ARG-TRP-OH HYDROCHLORIDE SALT; L-ARG-TRP SALT; H-Arg-Trp-OH; Arg-Trp-OH; L-Arg-L-Trp-OH |
Indinavir sulfate | 157810-81-6 | C36H49N5O8S | 711.87 | Crixivan sulfate; MK-639 sulfate; L-735524 sulfate; MK639 sulfate; L735524 sulfate; MK 639 sulfate; L 735524 sulfate |
Indinavir | 150378-17-9 | C36H47N5O4 | 613.79 | Crixivan; MK-639; L-735524; MK639; L735524; MK 639; L 735524 |
Indimitecan | 915360-05-3 | C25H21N3O6 | 459.458 | Indimitecan; LMP776; LMP-776 |
Indimilast | 1038825-85-2 | C37H40FN7O3S | 681.83 | N-[4-[1-[3-[4-[[(3S,5R)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]phenyl]-6-fluoro-2,4-dioxopyrido[2,3-d]pyrimidin-3-yl]cyclohexyl]-2-methyl-1,3-thiazole-4-carboxamide;N-{cis-4-[1-(4'-{[(3R,5S)-3,5-dimethylpiperazin-1-yl]methyl}[1,1'-biphenyl]-3-yl)-6-fluo |
Indigo Carmine | 860-22-0 | C16H8N2Na2O8S2 | 466.35 | 12070blue; 1311blue; 1H-Indole-5-sulfonicacid,2-(1,3-d; 1h-indole-5-sulfonicacid,2-(1,3-dihydro-3-oxo-5-sulfo-2h-indol-2-ylidene)-2,3; 1H-Indole-5-sulfonicacid,2-(1,3-dihydro-3-oxo-5-sulfo-2h-indol-2-ylidene)-2,3-dihydro-3-oxo-,disodiumsalt; 2')-biindolin |
Indigo | 482-89-3 | C16H10N2O2 | 262.26 | (2,2'-biindoline)-3,3'-dione; (2,2'-Biindoline)-3,3'-dione; (delta(2,2'(3h,3'h))-biindole)-3,3'-dione; (delta(2,2')-biindoline)-3,3'-dione; (delta(sup2,2')-biindoline)-3,3'-dione; (delta2,2'(3H,3'H)-Biindole)-3,3'-dione; (delta2,2'-Biindoline)-3,3'-dione; |
Indibulin | 204205-90-3 | C22H16ClN3O2 | 389.83 | 2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide; D 24851; D-24851; indibulin; N-(pyridin-4-yl)-(1-(4-chlorobenzyl)indol-3-yl)glycoxylamide; N-(pyridin-4-yl)-(1-(4-chlorobenzyl)indol-3-yl)glyoxylamide |
Incyclinide | 15866-90-7 | C19H17NO7 | 371.345 | Metastat; 4-dedimethylamino sancycline; CMT-3; COL 3. |
Incensole acetate | 34701-53-6 | C22H36O3 | 348.52 | GTPL4220; 1,5,9-trimethyl-12-(propan-2-yl)-15-oxabicyclo[10.2.1]pentadeca-5,9-dien-2-yl acetate |
Incensole | 22419-74-5 | C20H34O2 | 306.5 | |
INCB3344 | 1262238-11-8 | C29H34F3N3O6 | 577.59 | N-(2-(((3S,4S)-1-(4-(Benzo[d][1,3]dioxol-5-yl)-4-hydroxycyclohexyl)-4-ethoxypyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide |
INCB18424 | 1160597-27-2 | C17H18N6 | 306.37 | |
INCB16562 | 933768-63-9 | C19H11Cl2N5 | 380.232 | INCB16562; INCB-16562; INCB 16562. |
INCB057643 | 1820889-23-3 | C20H21N3O5S | 415.46 | INCB-057643; 2,2,4-trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-benzo[b][1,4]oxazin-3(4H)-one |
INCB054329 | 1628607-64-6 | C19H16N4O3 | 348.36 | INCB-054329; INCB-54329; 7-(3,5-Dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2(1H)-one |
INCB024360-analog | 914471-09-3 | C9H7ClFN5O2 | 271.64 | INCB-24360; INCB024360; INCB 024360; INCB-024360; indoleamine-2,3-dioxygenase inhibitor INCB024360. |
INCB 3284 dimesylate | 887401-93-6 | C26H31F3N4O4.2CH4O3S | 712.76 | N-[2-[[(3R)-1-[trans-4-hydroxy-4-(6-methoxy-3-pyridinyl)cyclohexyl]-3-pyrrolidinyl]amino]-2-oxoethyl]-3-(trifluoromethyl)-benzamide, dimethanesulfonate |
INCB 3284 | 887401-92-5 | C26H31F3N4O4 | 520.54 | N-(2-(((R)-1-((1r,4R)-4-hydroxy-4-(6-methoxypyridin-3-yl)cyclohexyl)pyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide dimethanesulfonate; INCB3284; INCB 3284; INCB-3284; INCB3284 mesylate; INCB3284 dimesylate |
INCA-6 | 3519-82-2 | C20H12O2 | 284.31 | 9,10-Dihydro-9,10-o-benzenoanthracene-1,4-dione; 9,10-Dihydro-9,10[1',2']-benzenoanthracene-1,4-dione; 1,4-Triptycenoquinone; 12,15-Dihydro-12,15-dioxotriptycene; NSC 25996; Triptycene-1,4-quinone |
Inauhzin | 309271-94-1 | C25H19N5OS2 | 469.58 | Inauhzin |
Inarigivir | 475650-36-3 | C20H26N7O10PS | 587.50 | ORI-9020; SB-9000 |
IN-1130 | 868612-83-3 | C25H20N6O | 420.47 | 3-((5-(6-Methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl) methyl)benzamide |
IN01001 | 501364-82-5 | C23H25N3O4S | 439.53 | N-(3-morpholin-4-ylpropyl)-5-oxo-6,11-dihydroindeno[1,2-c]isoquinoline-9-sulfonamide;INO-1001;5H-Indeno[1,2-c]isoquinoline-9-sulfonaMide, 6,11-dihydro-N-[3-(4-Morpholinyl)propyl]-5-oxo |
IMS 2186 | 1031206-36-6 | C18H16O4 | 296.32 | (3E)-3-[(3-hydroxy-4-methoxyphenyl)methylidene]-6-methylchromen-4-one |
IMR-1A | 331862-41-0 | C13H11NO5S2 | 325.353 | 2-[2-methoxy-4-[(E)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]phenoxy]acetic acid |
IMR-1 | 310456-65-6 | C15H15NO5S2 | 353.407 | ethyl 2-[2-methoxy-4-[(Z)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]phenoxy]acetate |
Impurity C of Alfacalcidol | 82266-85-1 | C35H49N3O4 | 575.78 | |
IMM 01 | 218795-74-5 | C12H17N3O2S | 267.35 | (E)-N-(tert-butyl)-2-((2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl)hydrazinecarbothioamide |
Imisopasem manganese | 218791-21-0 | C21H35Cl2MnN5 | 483.384 | M40403; M 40403; CG4419; SC-72325 |
Imirestat | 89391-50-4 | C15H8F2N2O2 | 286.236 | Imirestat; 2,7-Difluorospiro[9H-fluorene-9,4'-imidazolidine]-2',5'-dione; AL-1576; HOE-843 |
Imipramine-d3 HCl | 112898-42-7 | C19H21D3N2·HCl | 319.89 | 10,11-Dihydro-N-methyl-N-(methyl-d3)-5H-dibenz[b,f]azepine-5-propanamine |
Imiquimod Related Compound E | 99010-09-0 | C13H17N3 | 215.30 | N4-Isobutylquinoline-3,4-diamine |
Imiquimod Related Compound D | 853792-81-1 | C13H14N4 | 226.28 | 1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine; Desmethyl-N-propyl Imiquimod |
Imiquimod Related Compound C | 99010-64-7 | C14H14ClN3 | 259.74 | 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline, NSC 672965 |
Imiquimod Related Compound B | 99010-63-6 | C14H15N3O | 241.30 | Desamino Imiquimod N-Oxide; 1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinoline 5-Oxide; 1-Isobutyl-1H-imidazo[4,5-c]quinoline N-Oxide; USP Imiquimod Related Compound B; |
Imiquimod Related Compound A | 99010-24-9 | C14H15N3 | 225.30 | Desamino Imiquimod; 1-Isobutyl-1H-imidazo[4,5-c]quinoline; USP Imiquimod Related Compound A; 1-Isobutyl-1H-imidazo-[4,5-c]-quinoline |
Imiquimod maleate | 896106-16-4 | C18H20N4O4 | 356.38 | R 837 maleate |
Imiquimod hydrochloride | 99011-78-6 | C14H17ClN4 | 276.76 | R 837 hydrochloride |
Imiquimod | 99011-02-6 | C14H16N4 | 240.30 | 1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; R-837; S-26308; Aldara; TMX-101 |
Imiprothrin | 72963-72-5 | C17H22N2O4 | 318.37 | Imiprothrin (mixture of isomers) PESTANAL; Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2,5-dioxo-3-(2-propynyl)-1-imidazolidinylmethyl ester; imiprothrin (bsi, pa e-iso); s-41311; 2,5-Dioxo-3-prop-2-ynylimidazolidin-1-ylmethyl (1R |
Imipramine-2,4,6,8-d4 Hydrochloride | 61361-33-9 | C19H21D4ClN2 | 320.89 | 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine-d4 Hydrochloride; Chrytemin-d4; Imiprin-d4; G-22355-d4; Tofranil-d4 |
Imipramine Pamoate | 10075-24-8 | C23H16O6.2C19H24N2 | 949.199 | 4,4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propylamine (1:2) |
Imipramine N-Glucuronide | 165602-94-8 | C25H32N2O6 | 456.53 | N-b-D-Glucopyranuronosyl-10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanaminium inner salt |
Imipramine Impurity HCl (9-Methyl-10-Dimethylaminopropylacridinium Chloride HCl) | 70738-29-3 | C19H24N2Cl2 | 351.32 | 9-Methyl-10-Dimethylaminopropylacridinium Chloride HCl |
Imipramine Impurity B HCl | 58262-51-4 | C19H23N2Cl | 314.85 | N,N-Dimethyl-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride; G 31406 Hydrochloride; 10,11-Dehydroimipramine Hydrochloride, Depramine Hydrochloride |
Imipiramine N-Oxide | 6829-98-7 | C19H24N2O | 296.42 | 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine N-Oxide; 5-[3-(Dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine 5-oxide |
Imipenem-d4 | 1261396-26-2 | C12H13N3O4SD4 | 303.38 | |
Imipenem, Monohydrate | 74431-23-5 | C12H19N3O5S | 317.36 | |
Imino-tris(dimethylamino)phosphorane | 49778-01-0 | C6H19N4P | 178.22 | N,N,N,N,N,N-Hexamethylphosphorimidic triamide, Phosphazene base P1-H |
Iminostilbene N-Carbonyl Chloride | 33948-22-0 | C15H10ClNO | 255.71 | 5H-Dibenz[b,f]azepine-5-carbonyl Chloride; 5-(Chlorocarbonyl)-5H-dibenz[b,f]azepine; N-(Chlorocarbonyl)-5H-dibenz[b,f]azepine |
Iminodibenzyl 5-Carbonyl Chloride | 33948-19-5 | C15H12ClNO | 257.72 | 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carbonyl Chloride; 5-(Chlorocarbonyl)-10,11-dihydrodibenzazepine; 5-Chlorocarbonyl-10,11-dihydro-5H-dibenz[b,f]azepine; Carbamazepine Dihydro Chlorocarbonyl Impurity |
Iminodiacetic acid disodium salt | 928-72-3 | C4H5NNa2O4 | 177.07 | Glycine,N-(carboxymethyl)-,disodiumsalt; iminodi-aceticacidisodiumsalt; iminodioctandisodny; iminodioctansodny; n-(carboxymethyl)-glycindisodiumsalt; IMINODIETHANOIC ACID DISODIUM SALT; IMINODIACETIC ACID DI NA SALT; IMINODIACETIC ACID DISODIUM SALT |
Iminodiacetic acid | 142-73-4 | C4H7NO4 | 133.1 | 2,2'-iminobis-aceticaci; 2,2'-iminodiaceticacid; 2,2'-Iminodiacetic acid; Acetic acid, 2,2'-iminobis-; Acetic acid, iminodi-; aminodiacetic; Aminodiacetic acid; Aminodiaceticacid |
Imiloxan hydrochloride | 81167-22-8 | C14H17N2O2Cl | 280.75 | RS 21361; 2-(1-Ethyl-2-indazoyl)methyl-1,4-benzodioxan hydrochloride; 1,4-Benzodioxin, 1H-imidazole Derivative |
Imiglitazar | 250601-04-8 | C28H26N2O5 | 470.52 | (4E)-4-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methoxyimino]-4-phenylbutanoic acid; Imiglitazar; TAK 559; TAK-559; TAK559 |
Imidodisulfurylchloride | 15873-42-4 | |||
Imidodicarbonic acid, 2-[4-[[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]imino]butyl]-, 1,3-bis(1,1-dimethylethyl) ester | 865202-95-5 | C22H33N3O4 | 403.51500 | |
Imidodicarbonic acid, 2-[4-[[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]amino]butyl]-, 1,3-bis(1,1-dimethylethyl) ester, hydrochloride (1:1) | 865202-96-6 | C22H36ClN3O4 | 441.99200 | |
Imidocarb Dipropionate | 55750-06-6 | C25H32N6O5 | 496.56 | N,N-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea) dipropionate |
Imidocarb 2HCl | 5318-76-3 | C19H22Cl2N6O | 421.326 | 1,3-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]-urea dihydrochloride hydrate |
Imidocarb | 27885-92-3 | C19H20N6O | 348.4 | IMIDOCARB; 1,3-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]urea; 3,3'-di-2-imidazolin-2-yl-carbanilid; n,n'-bis(3-(4,5-dihydro-1h-imidazol-2-yl)phenyl)-ure; n,n'-bis(3-(4,5-dihydro-1h-imidazol-2-yl)phenyl)urea; N,N'-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)phe |
Imazethapyr Impurity 9 | 102268-15-5 | C9H9NO4 | 195.18 | 5-Ethylquinolinic Acid; 5-Ethyl-2,3-pyridinedicarboxylic Acid; 5-ethylpyridine-2,3-dicarboxylic acid |
Imazethapyr Impurity 8 | 202586-58-1 | C14H19N3O | 245.33 | |
Imazethapyr Impurity 16 | 89084-60-6 | C14H19N3O | 245.33 | 3-Descarboxy Imazethapyr |
Imazethapyr Impurity 15 | 113052-10-1 | C15H17N3O4 | 303.32 | |
Imazethapyr Impurity 14 | 102771-62-0 | C13H15N3O4 | 277.28 | |
Imazethapyr Impurity 13 | 134887-87-9 | C15H19N3O4 | 305.34 | 5-(1-Hydroxyethyl) Imazapyr |
Imazethapyr Impurity 11 | 1360885-08-0 | C9H9NO2 | 163.18 | |
Imazethapyr Impurity 10 | 102268-21-3 | C15H19N3O3 | 289.34 | |
Imazethapyr Impurity | 105151-39-1 | C13H17NO4 | 251.28 | Diethyl 5-ethylpyridine-2,3-dicarboxylate; 5-Ethyl-2,3-pyridinedicarboxylic Acid Diethyl Ester; |
Imazethapyr | 81335-77-5 | C15H19N3O3 | 289.34 | (±)-5-Ethyl-2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)nicotinic Acid; (±)-Imazethapyr; 5-Ethyl-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) Nicotinic Acid; AC 263499; CL 263499; Fabian; Imazethapyr; Pivot; Pursuit; Pursuit 10 |
Imazaquin ammonium | 81335-47-9 | C17H20N4O3 | 328.37 | Imazaquin ammonium; 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-3-quinolinecarboxylic acid monoammonium salt; ammonium imazaquin; 2-(4,5-Dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-3-quinolinecarboxylic acid monoammoni |
Imazapyr | 81334-34-1 | C13H15N3O3 | 261.28 | |
Imazameth | 104098-48-8 | C14H20N4O3 | 292.33 | Imazapic;Imazameth;Imazmethapyr;104098-48-8;Imazamethapyr;Imazapic[ISO] |
Imazalil-D5 | 1398065-91-2 | 1-[2-Allyloxy-D5-2-(2,4-dichloro phenyl) ethyl]-1H-imidazole | ||
Imatinib-d3(N-methyl-d3) | 1134803-18-1 | C29H23D3N7O | 496.63 | 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide |
Imatinib Related Compound | 152460-09-8 | C16H13N5O2 | 307.31 | N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine; (2-Methyl-5-nitrophenyl)[4-(pyridin-3-yl)pyrimidin-2-yl]amine; 2-Methyl-5-nitro-N-[4-(pyridin-3-yl)pyrimidin-2-yl]benzenamine; |
Imatinib meta-Methyl-Piperazine Impurity | 1246819-59-9 | C29H31N7O | 493.62 | 3-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-pyridinyl)-2-pyrimidinylamino]phenyl]benzam |
Imatinib Mesylate | 220127-57-1 | C29H31N7O.CH4SO3 | 589.71 | Gleevec; Glivec; Imatinib mesilate; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide mesylate |
Imatinib intermediate (N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-Chloromethyl Benzamide) | 404844-11-7 | C24H20ClN5O | 429.91 | N-[5[[4-(Chloromethyl)benzoyl]amino]-2-methylphenyl]4-(3-pyridyl)-2-pyrimidine |
Imatinib Impurity H | 1026753-54-7 | C29H31N7O | 493.62 | Imatinib para-Diaminomethylbenzene; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide |
Imatinib Impurity E | 1365802-18-1 | C52H48N12O2 | 873.04 | Des(methylpiperazinyl-N-methyl) Imatinib Dimer Impurity; 4,4'-(piperazine-1,4-diylbis(methylene))bis(N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide) |
Imatinib Impurity C | 938082-57-6 | C29H31N7O2 | 509.62 | Imatinib (Piperidine)-1-oxide; 4-[(4-Methyl-1-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; |
Imatinib Impurity B | 571186-93-1 | C29H31N7O3 | 525.62 | Imatinib (Piperidine)-N,N-dioxide; 4-[(4-Methyl-1,4-dioxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; |
Imatinib Impurity A | 571186-92-0 | C29H31N7O2 | 509.62 | N-[4-Methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide; CGP 72383; |
Imatinib Impurity 8 | 1356565-46-2 | C42H47N9O2 | 709.90 | Gleevec N-4-((4-Methylpiperazin-1-yl)methyl)benzaldehyde; N-(2-Methyl-5-(4-((4-methylpiperazin-1-yl)methyl)benzamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)benzamide |
Imatinib Impurity 7 | 581076-64-4 | C8H12N4 | 164.21 | N-(5-Amino-2-methylphenyl)guanadine |
Imatinib Impurity 6 | 112696-91-0 | C16H15N5 | 277.33 | N-(4-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine; 3-Methyl-4-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline; 2-Methyl-N1-[4-(3-pyridinyl)-2-pyrimidinyl]-1,4-benzenediamine; |
Imatinib Guanidine Impurity | 581076-65-5 | C21H28N6O | 380.50 | N-(3-Guanidino-4-methylphenyl)-4-(methylpiperazine-1-yl-methyl)benzamide; N-[3-[(Aminoiminomethyl)amino]-4-methylphenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide N-[2-Methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]benzoyl]amino]phenyl]guanidine |
Imatinib EP Impurity J | 571186-91-9 | C29H31N7O2 | 509.62 | 4-[(4-Methyl-4-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; CGP 71422; |
Iloperidone N-Oxide | 1375651-09-4 | C24H27FN2O5 | 442.49 | 1-(3-(4-Acetyl-2-methoxyphenoxy)propyl)-4-(6-fluorobenzo[d]isoxazol-3-yl) piperidine 1-oxide |
Iloperidone metabolite P95 | 475110-48-6 | C23H25FN2O5 | 428.46 | 4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxybenzoic Acid; P 95-12113; |
Iloperidone Impurity 9 | 691007-07-5 | C12H14F2N2O | 240.25 | (E)-4-(2,4-Difluorobenzoyl)piperidine Oxime; (1E)-(2,4-Difluorophenyl)-4-piperidinyl-methanone Oxime |
Iloperidone Impurity 4 | 133455-04-6 | C25H29FN2O4 | 440.52 | 1-Desacetyl 1-Propionyl Iloperidone; 1-(4-(3-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxyphenyl)propan-1-one |
Iloperidone Impurity 3 | 170170-50-0 | C24H28FNO5 | 429.49 | 1-[4-[3-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]propoxy]-3-methoxyphenyl]-ethanone |
Iloperidone Impurity 2 | 1309041-89-1 | C19H22O6S | 378.45 | 4'-(3-p-toluenesulfonylpropoxy)-3'-methoxyacetophenone |
Iloperidone Impurity 13 | 531524-17-1 | C24H25FN4O2 | 420.49 | 6-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-3-(4-piperidinyl)-1,2-benzisoxazole |
Iloperidone Impurity 1 | 207298-39-3 | C12H16O4 | 224.26 | 1-[4-(3-Hydroxypropoxy)-3-methoxyphenyl]-ethanone |
Iloperidone hydrochloride | 1299470-39-5 | C24H28ClFN2O4 | 465.96 | Iloperidone D3 Hydrochloride; CS-O-02812 |
Iloperidone Dimer Impurity | 1375651-23-2 | C36H39FN4O5 | 626.73 | 1-{4-[3-(4-{6-[4-(6-Fluoro-3a,7a-dihydro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-3a,7a-dihydro-benzo[d]isoxazol-3-yl}-piperidin-1-yl)-propoxy]-3-methoxy-phenyl}-ethanone |
Iloperidone | 133454-47-4 | C24H27FN2O4 | 426.48 | HP873; HP 873; HP-873 |
Ilonidap | 135202-79-8 | C14H8ClFN2O3S | 338.74 | (3Z)-6-chloro-5-fluoro-3-[hydroxy(thiophen-2-yl)methylidene]-2-oxoindole-1-carboxamide;Ilonidap(USAN/INN);SCHEMBL42518;135202-79-8;D04506 |
Ilomastat | 142880-36-2 | C20H28N4O4 | 388.468 | Galardin; GM6001; GM 6001; (2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanedia |
Ilimaquinone | 71678-03-0 | C22H30O4 | 358.5 | |
Ilicol | 72715-02-7 | C15H26O2 | 238.4 | 4alphaH-Eudesm-11(13)-ene-4,12-diol; Ilicic alcohol |
IHR 1 | 548779-60-8 | C20H12Cl4N2O2 | 454.13 | N,N'-1,4-Phenylenebis[2,5-dichlorobenzamide] |
IHDA | 2536-36-9 | C16H31IO2 | 0 | Hexadecanoic acid, 16-iodo-; IHDA |
Ibodutant | 522664-63-7 | C37H48N4O4S | 644.87 | MEN-15596;MEN15596;6-Methyl-N-[1-[[(2R)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide;(R)-6-methyl-N-(1-((1-oxo-3-phenyl-1-(((1-((tetrahydro-2H-pyran-4-yl)methyl)piperidi |
Ibrutinib Impurity 3 | 1226872-27-0 | C25H26N6O4 | 474.52 | PCI-45227 |
Ibrutinib Impurity 1 | 1022150-11-3 | C27H30N6O3 | 486.58 | 1-Piperidinecarboxylic acid, 3-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]-, 1,1-diMethylethyl ester, (3R)-; (R)-tert-Butyl 3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate |
Ibrutinib D5 | 1553977-17-5 | C25H19D5N6O2 | 445.53 | 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one-d5; PCI 32765-d5; PCI 32765-00-d5; CRA 032765-d5; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one- |
Ibrutinib | 936563-96-1 | C25H24N6O2 | 440.51 | PCI32765; PCI-32765; PCI 32765; 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one |
I-BRD9 | 1714146-59-4 | C22H22F3N3O3S2 | 497.55 | N'-(1,1-dioxothian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide I-BRD9 N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-dihydrothieno[3,2-c]pyridine-2-carboximidamide |
Ibopamine | 66195-31-1 | C17H25NO4 | 307.385 g/mol | |
I-BOP | 128719-90-4 | C23H29IO5 | 512.4 | (Z)-7-[(1S,2R,3R,4R)-3-[(E,3R)-3-hydroxy-4-(4-iodophenoxy)but-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid |
Ibogamine-18-carboxylicacid, 13-hydroxy-, methyl ester (9CI) | 76202-23-8 | C21H26 N2 O3 | 354.4427 | |
IBMX | 28822-58-4 | C10H14N4O2 | 222.24 | 3-Isobutyl-1-methylxanthine; isobutylmethylxanthine; 1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione |
Ibipinabant | 464213-10-3 | C23H20Cl2N4O2S | 487.40 | (S)-SLV 319; BMS 646256; 3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4S-phenyl-1H-pyrazole-1-carboximidamide; |
Hydroxy Loxoprofen | 83599-40-0 | C15H20O3 | 248.32 | |
Hydroxy Ivabradine | 1235547-07-5 | C15H21NO4 | 279.34 | 1,3,4,5-Tetrahydro-3-(3-hydroxypropyl)-7,8-dimethoxy-2H-3-benzazepin-2-one; 3-(3-Hydroxypropyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one |
Hydralazine-15N4 | 1346747-08-7 | C8H8[15N]4 | 164.15 | 1-[(1,2-15N2)hydrazin-1-yl](2,3-15N2)phthalazine |
Hydroxy Itraconazole-D8 | 1217516-26-1 | C35H30D8Cl2N8O5 | 729.68 | 4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl-d8)-3H-1,2,4-triazol-3-one; R 63373-d8; |
Hydroxy Itraconazole | 112559-91-8 | C35H38Cl2N8O5 | 721.65 | 4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)-3H-1,2,4-triazol-3-one; |
Hydroxy Ipronidazole-d3 | 1156508-86-9 | 2-(1-Methyl-D3-5-nitro- 1H-imidazol-2-yl)- propan-2-ol; Ipronidazole-OH-(N-methyl-d3) | ||
Hydroxy Ipronidazole | 35175-14-5 | 2-(1-Methyl-5-nitro-1H- imidazol-2-yl)-propan-2- ol; Ipronidazole-OH | ||
Hexahydro-pyrrolo[1,2-a]pyrazin-6-one | 117810-52-3 | C7H12N2O | 140.18 | HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-6-ONE; Hexahydropyrrolo[1,2-a]pyrazin-6(2H)-one; Pyrrolo[1,2-a]pyrazin-6(2H)-one, hexahydro- |
HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-1-ONE | 16620-61-4 | C7H12N2O | 140.18 | HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-1-ONE; AKOS AL-18; UKRORGSYN-BB BBV-182066; HEXAHYDROPYRROLO[1,2-A]PYRAZIN-1(2H)-ONE |
hexahydro-pyrimidine-2,4,6-trione | 67-52-7 | C4H4N2O3 | 128.09 | SPECS AG-670/31547005; TIMTEC-BB SBB004242; PYRIMIDINE TRIONE; N,N'-MALONYLUREA; 2,4,6-Pyrimidinetriol; 2,4,6-pyrimidinetrione; 2,4,6-Pyrimidinetrione(1H,3H,5H); 2,4,6-Trioxohexahydropyrimidine |
HEXAHYDROPYRIDAZINE-3-CARBOXYLIC ACID | 32750-52-0 | C5H10N2O2 | 130.15 | PIPERAZIC ACID; HEXAHYDROPYRIDAZINE-3-CARBOXYLIC ACID; 3-Pyridazinecarboxylic acid, hexahydro-; Hexahydropyridazine-3-carboxylic acid, tech.; Piperazic acid, tech.; Piperidazine-3-carboxylic acid |
Hexahydrophthalic anhydride, HHPA | 85-42-7 | C8H10O3 | 154.16300 | |
Hexahydroindolizin-8-one | 2407-98-9 | C8H13NO | 139.19 | HEXAHYDRO-INDOLIZIN-8-ONE; hexahydro-8(5H)-Indolizinone |
hex-1-en-2-ylbenzene | 20826-80-6 | C12H16 | 160.255 g/mol | hex-1-en-2-ylbenzene; NORFORMINDERIV; WIN34997; 20826-80-6; .alpha.-Butylstyrene; 2-Phenyl-1-hexene |
Heveaflavone | 23132-13-0 | C33H24O10 | 580.6 | 2-(4-Methoxyphenyl)-5-hydroxy-7-methoxy-8-[2-hydroxy-5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)phenyl]-4H-1-benzopyran-4-one |
Heudelotinone | 133453-58-4 | C18H20O2 | 268.4 | (11aR)-7-Hydroxy-1,1,8-trimethyl-1,10,11,11a-tetrahydro-2H-dibenz o[a,d][7]annulen-2-one |
Heterophyllin B | 145459-19-4 | C40H58N8O8 | Cyclo(glycylglycyl-L-leucyl-L-prolyl-L-prolyl-L-prolyl-L-isoleucyl-L-phenylalanyl); 1H,25H-Tripyrrolo[1,2-a:1',2'-d:1'',2''-g][1,4,7,10,13,16,19,22]octaazacyclotetracosine,cyclic peptide deri | |
Heteroclitin D | 140369-76-2 | C27H30O8 | 2-Butenoic acid,2-methyl-,(6R,7R,8R,14aS)-5,6,7,8-tetrahydro-2,3-dimethoxy-6,7-dimethyl-1-oxo-1H,14H-benzo[1,8]cycloocta[1,2,3-cd][1,3]dioxolo[4,5-g]benzofuran-8-ylester, (2Z)- | |
GSK3117391 | 1018673-42-1 | C22H33N3O4 | 403.52 | HDAC-IN-3; SCHEMBL15144242; AFDPFLDWOXXHQM-NRFANRHFSA-N; CS-5448; HY-19772; 121555-EP2295410A1 |
GSK3 Inhibitor XIII | 404828-08-6 | C18H19N5 | 305.4 | Glycogen Synthase Kinase 3 Inhibitor XIII; 5,6,7,8-tetrahydro-N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl-4-quinazolinamine |
GSK-3 inhibitor 1 | 603272-51-1 | C22H17ClFN5O2 | 437.85 | |
GSK299423 | 1352149-24-6 | C25H27N5O2S | 461.58 | 4-(2-(4-(([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-6-methoxyquinoline-3-carbonitrile |
GSK299115A | 864082-35-9 | C20H16Cl2N4O2 | 415.27 | 4-(3,4-dichlorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1H-pyridine-5-carboxamide |
GSK2982772 | 1622848-92-3 | C20H19N5O3 | 377.4 | 5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide |
Iguratimod | 123663-49-0 | C17H14N2O6S | 374.367 | T 614; T-614; T614; N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide; Careram; Kolbet; UNII-4IHY34Y2NV |
IG-105 | 905978-63-4 | C20H19N3O4S | 397.448 | IG-105; IG105; IG 105 |
Ifosfamide-d4 | 1189701-13-0 | C7H11D4Cl2N2O2P | 265.11 | N,3-bis(2-chloroethyl)-4,4,5,5-tetradeuterio-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine |
Ifosfamide Impurity F | 81485-04-3 | C5H10Cl2NO2P | 218.02 | |
Ifosfamide Impurity E | 42453-19-0 | C5H11Cl2N | 156.06 | 3-chloro-N-(2-chloroethyl)propan-1-amine |
Ifosfamide Impurity B | 241482-18-8 | C10H24Cl2N2O7P2 | 417.17 | Bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate |
Idoxifene | 116057-75-1 | C28H30INO | 523.458 | Idoxifene |
IDO-IN-8 | 1402837-77-7 | C18H21FN2O2 | 316.37 | (1S,4r)-4-((S)-2-((R)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol |
IDO-IN-7 | 1402837-78-8 | C18H21FN2O2 | 316.37 | (1R,4r)-4-((R)-2-((S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol |
Hypoxanthine | 68-94-0 | C5H4N4O | 136.11 | CB 676475 |
Hypothemycin | 76958-67-3 | C19H22O8 | 378.377 | Hypothemycin |
Hypophyllanthin | 33676-00-5 | C24H30O7 | 430.5 | (7R,9S)-9-(3,4-dimethoxyphenyl)-4-methoxy-7,8-bis(methoxymethyl)-6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxole |
Hypophosphoric acid,sodium salt (1:4) | 13721-43-2 | H4O6 P2 . 4 Na | 249.903 g/mol | tetrasodium; dioxido-oxo-phosphonato-$l^{5}-phosphane; 13721-43-2; Hypophosphoricacid,tetrasodiumsalt; Tetrasodiumhypophosphate; AC1L1VPD |
Hyponine E | 226975-99-1 | C45H48N2O19 | 920.874 | (-)-Hyponine E |
Hyponine D | 259823-31-9 | C47H50N2O18 | 930.913 | |
Hydrocarbon chain derivative 1 | 300762-25-8 | C16H34O3 | 274.44 | 1-Hexanol, 6,6'-oxybis[2,2-dimethyl-; 6-(6-hydroxy-5,5-dimethylhexoxy)-2,2-dimethylhexan-1-ol |
Hydrobromic acid solution | 37348-16-6 | HBr | 80.91194 | Hydrogen bromide |
HYDROABIETYL ALCOHOL | 26266-77-3 | C20H34O | 290.48 | dihydro-abietylalcoho; dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethano; dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-1-Phenanthrenemethanol; ABITOL; DIHYDROABIETYL ALCOHOL; HYDROABIETYL ALCOHOL |
HLCL-61 hydrochloride | 1158279-20-9 | C23H25ClN2O | 380.91 | 1-(9-ethyl-9H-carbazol-3-yl)-N-(2-methoxybenzyl)methanamine hydrochloride; HLCL61; HLCL 61; HLCL-61 |
Hoechst 33342 trihydrochloride | 875756-97-1 | C27H28N6O·3HCl | 561.9 | Bisbenzimide Ethoxide Trihydrochloride; 2'-(4-ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-1H-benzimidazole trihydrochloride |
Heptyl-2-naphthol | 31215-04-0 | C31H50O53 | 242.35598 | Heptyl-2-naphthol; 1-heptyl-2-naphthol; 1-heptylnaphthalen-2-ol; 2-Naphthalenol,heptyl-; 31215-04-0; EINECS250-513-0 |
heptyl octadecanoate | 24466-84-0 | C25H50O2 | 382.663 g/mol | Heptylstearate;heptyloctadecanoate;24466-84-0;heptylstearate;AC1L3K5O;Octadecanoicacidheptylester |
Heptyl heptanoate | 624-09-9 | C14H28O2 | 228.371 g/mol | |
heptyl butyrate | 5870-93-9 | C11H22O2 | 186.29 | butanoicacid,heptylester; Butyric acid, heptyl ester; butyricacid,heptylester; Heptyl butanoate; heptylbutanoate; n-Heptyl butanoate; n-Heptyl n-butyrate; N-HEPTYL BUTYRATE |
Heparin derived dp4 saccharide ammonium salt | 61844-85-7 | Av 1200 | Tetrasaccharide (dp4) | |
Heptakis(2,3-di-O-acetyl-6-sulfo)-beta-cyclodextrin sodium salt | 196398-66-0 | C70H91O70S7Na7 | 2437.8 | |
Heptakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)cyclomaltoheptaose | 123172-94-1 | C112H196O49Si7 | 2523.32 | Silyl(6-O-tert-butyldimethyl)-2,3-di-acetyl)-b-cyclodextrin; Heptakis(6-O-tert-butyldimethylsilyl)-b-cyclodextrin tetradecaacetate |
Guanethidine sulfate | 645-43-2 | C10H24N4O4S | 296.39 | Guanethidine monosulfate |
Guanclofine | 55926-23-3 | C9H12Cl2N4 | 247.128 | Guanclofine; 55926-23-3; UNII-9D89762N7C; 2-{2-[(2,6-dichlorophenyl)amino]ethyl}guanidine; Guanclofina; Guanclofinum |
Guancidine | 1113-10-6 | C7H14N4 | 154.213 g/mol | Guancidine; Guancydine; Guancydine[USAN]; 1113-10-6; Guancidinum[INN-Latin]; Guancidina[INN-Spanish] |
Guanadrel Hemisulfate | 22195-34-2 | C10H19N3O2.1/2H2O4S | 524.636 | N-(1,4-Dioxaspiro[4.5]dec-2-ylmethyl)guanidine Sulfate; (1,4-Dioxaspiro[4.5]dec-2-ylmethyl)guanidine Sulfate; Anarel; CL 1388R; Guanadrel Sulfate; Hylorel; U 28288D |
Guanadrel | 40580-59-4 | C10H19N3O2 | 213.279 | Guanadrel; 1-(1,4-Dioxaspiro[4.5]decan-2-ylmethyl)guanidine; C07035 |
Guanabenz hydrochloride | 23113-43-1 | C8H8Cl2N4·HCl | 267.5 | Wytensin; 2-[(2,6-dichlorophenyl)methylene]-hydrazinecarboximidamide, monohydrochloride |
Guanabenz Acetate | 23256-50-0 | C8H8Cl2N4.C2H4O2 | 291.13 | WY-8678 Acetate |
Guajadial F | 1529775-08-3 | C30H34O5 | 474.597 | (5aS,7S,10R,10aR,11aR,12R)-1,3-dihydroxy-5a,10-dimethyl-12-phenyl-7-propan-2-yl-7,8,9,10,10a,11,11a,12-octahydrobenzo[b]xanthene-2,4-dicarbaldehyde |
Guajadial E | 1529775-06-1 | C30H34O5 | 474.597 | (5aS,7S,10R,10aR,11aR,12S)-1,3-dihydroxy-5a,10-dimethyl-12-phenyl-7-propan-2-yl-7,8,9,10,10a,11,11a,12-octahydrobenzo[b]xanthene-2,4-dicarbaldehyde |
Guajadial D | 1529775-04-9 | C30H34O5 | 474.597 | (1S,4R,4'S,4aR,7S)-5',7'-dihydroxy-4-methyl-4'-phenyl-1-propan-2-ylspiro[2,3,4,4a,5,6-hexahydro-1H-naphthalene-7,2'-3,4-dihydrochromene]-6',8'-dicarbaldehyde |
Guajadial C | 1529775-02-7 | C30H34O5 | 474.597 | (1S,4R,4'R,4aR,7S)-5',7'-dihydroxy-4-methyl-4'-phenyl-1-propan-2-ylspiro[2,3,4,4a,5,6-hexahydro-1H-naphthalene-7,2'-3,4-dihydrochromene]-6',8'-dicarbaldehyde |
IDO-IN-6 | 1402837-76-6 | C18H21FN2O2 | 316.37 | (1S,4r)-4-((S)-2-((S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol |
IDO-IN-5 | 1402837-79-9 | C18H21FN2O2 | 316.37 | (1R,4r)-4-((R)-2-((R)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol |
IDO-IN-4 | 1629125-65-0 | C26H35N3O3 | 437.57 | (1R,2S)-2-(4-(diisobutylamino)-3-(3-(p-tolyl)ureido)phenyl)cyclopropanecarboxylic acid |
IDO-IN-1 | 914638-30-5 | C9H7BrFN5O2 | 316.09 | IDO-IN-1; IDO-IN1; |
IDO inhibitor 1 | 1204669-37-3 | C11H13BrFN7O4S | 438.23 | (E)-N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide |
IDN-1965 | 204919-14-2 | C21H26FN3O5 | 419.453 | IDN-1965; IDN1965; IDN 1965. |
IDH305 | 1628805-46-8 | C23H22F4N6O2 | 490.45 | (4R)-4-[(1S)-1-fluoroethyl]-3-[2-({(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethyl}amino)pyrimidin-4-yl]-1,3-oxazolidin-2-one |
IDFP | 615250-02-7 | C15H32FO2P | 294.4 | Isopropyl Dodecylfluorophosphonate; 1-[fluoro(propan-2-yloxy)phosphoryl]dodecane |
IDF-11774 | 1429054-28-3 | C23H32N2O2 | 368.51 | EX-A3002; 2-[4-(1-adamantyl)phenoxy]-1-(4-methylpiperazin-1-yl)ethanone |
Ibuprofen lysine | 57469-77-9 | C19H32N2O4 | 352.47 | |
Ibuprofen lysinate | 57469-76-8 | C19H32O4N2 | 352.48 | 2-(4-Isobutylphenyl)propionic acid lysinate |
Ibuprofen Impurity R | 102120-87-6 | C22H30 | 294.48 | 1,1-Bis(p-isobutylphenyl)ethane; 1,1'-(Ethane-1,1-diyl)-4,4'-(2-methylpropyl)dibenzene; 1,1'-Ethylidenebis[4-(2-methylpropyl)-benzene |
Ibuprofen Impurity Q | 36039-35-7 | C12H18O | 178.28 | 4-(2-Methylpropyl)benzeneethanol; (p-Isobutylphenyl)ethanol; 2-(4-Isobutylphenyl)ethyl Alcohol; 4-Isobutylphenylethanol; NSC 69112 |
Hexanoyl-L-homoserine lactone | 147852-83-3 | C10H17NO3 | 199.3 | C6-HSL, N-Hexanoyl-L-homoserine lactone |
Hexalactone | 823-22-3 | C6H10O2 | 114.14 | caprolactone |
Hexanoyl-L-carnitine chloride | 162067-53-0 | C13H26NO4·Cl | 295.80 | Caproyl-L-Carnitine; C6 Carnitine; L-Hexanoylcarnitine |
Hexanoic acid,6-amino-, methyl ester, hydrochloride (1:1) | 1926-80-3 | C7H15 N O2 . Cl H | 181.66 | METHYL 6-AMINOHEXANOATE HYDROCHLORIDE; METHYL 6-AMINOCAPROATE HYDROCHLORIDE; TIMTEC-BB SBB003739; Methyl 6-aminocappoate hydrochloride |
Hexanoic acid,6,6'-dithiobis- | 92038-67-0 | C12H22 O4 S2 | 294.43068 | 5-CARBOXYPENTYL DISULFIDE; 5-Carboxypentyldisulfide6,6'-Dithiodihexanoicacid |
GSK583 | 1346547-00-9 | C20H19FN4O2S | 398.46 | |
GSK554418A | 871819-90-8 | C19H19ClN4O2 | 370.84 | (4-((3-chlorophenyl)amino)-1-methyl-1H-pyrrolo(3,2-C)pyridin-7-yl)-4-morpholinyl- Methanone |
GSK-5498A | 1253186-49-0 | C18H11F6N3O | 399.29 | 2,6-Difluoro-N-(1-(2-fluoro-6-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide |
GSK547 | 2226735-55-1 | C20H18F2N6O | 396.39 | RIP1i |
GSK525762 | 1260907-17-2 | C22H22ClN5O2 | 423.9 | GSK525762; GSK525762; GSK525762; GSK525762A; GSK-525762A; GSK 525762A; I-BET-762; I-BET762; I-BET 762. |
GSK-503 | 1346572-63-1 | C31H38N6O2 | 526.67 | GSK503; GSK 503; GSK503. |
GSK-484 | 1652591-81-5 | C27H32ClN5O3 | 510.04 | GSK484; ((3S,4R)-3-Amino-4-hydroxypiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-indol-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride |
GR 113808 | 144625-51-4 | C19H27N3O4S | 393.5 | 1-methyl-1H-indole-3-carboxylic acid, [1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]methyl ester |
GR 103691 | 162408-66-4 | C30H35N3O3 | 485.62 | 4'-Acetyl-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-[1,1'-biphenyl]-4-carboxamide |
GPX150 | 236095-29-7 | C27H32N2O9 | 565.02 | GPX150 |
GPX100 | 952648-77-0 | C27H31NO10 | 529.536 | GPX100; 13-deoxy-doxorubicin. |
G-Protein antagonist peptide | 143675-79-0 | C57H64N12O9S | 1093.27 | GPAnt-2 |
GPR40 Activator 2 | 1312787-30-6 | C28H29NO6S2 | 539.66 | GPR40 Activator 2 |
GPR40 Activator 1 | 1309435-60-6 | C31H31NO3S | 497.65 | GPR40 Activator 1 |
GPR120-IN-1 | 1599477-75-4 | C19H23ClF3NO3 | 405.84 | 2-[3-[2-chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecan-9-yl]acetic acid; GPR120 Compound A; MDK77754; MDK-77754; MDK 77754; GPR120 cpdA |
Gala1-3Galb1-4GlcNAcb1-3Galb1-4Glcb | 177331-58-7 | C32H55NO26 | 869.77 | a-Gal epitope type III |
GAL-021 | 1380341-99-0 | C11H22N6O | 254.33 | 2-N-methoxy-2-N-methyl-4-N,6-N-dipropyl-1,3,5-triazine-2,4,6-triamine; GAL-021; GAL021 |
Fucoidan - Ascophyllum nodosum | 9072-19-9 | (C6H9O3SO3)n | Sulfated L-fucan | |
Calteridol | 120041-08-9 | C17H32N4O7 | 404.46 | calteridol; CHEBI:37387; 1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid,10-(2-hydroxypropyl)-; 2,2',2'-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid; ACMC-20mop4 |
Gadoteridol | 120066-54-8 | C17H29GdN4O7 | 558.68 | [10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]gadolinium; 1,4,7,10-Tetraazacyclododecane Gadolinium deriv.; 10-(2-Hydroxypropyl)-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic Acid Gadolinium Complex; |
Gadoteric acid | 72573-82-1 | C16H25GdN4O8 | 558.65 | Gadoteric acid; Gadoteric; Gadolinium 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetic acid |
Gadopentetate dimeglumine | 86050-77-3 | C28H54GdN5O20 | 938 | 2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; Diethylenetriaminepenta-acetic Acid, Gadolinium; Dimeglumine, Gadolinium DTPA; Dimeglumine, Gadopentetate; DTPA, Gadol |
Idelalisib-d5 | 1830330-31-8 | C22H13FN7OD5 | 420.46 | 5-fluoro-3-(D5)phenyl-2-[(1S)-1-[(7H-purin-6-yl)amino]propyl]-3,4-dihydroquinazolin-4-one |
Idelalisib | 870281-82-6 | C22H18FN7O | 415.432 | Idelalisib; CAL101; CAL 101; CAL-101; GS1101; GS 1101; GS-1101, Idelalisib. |
Icaritin | 118525-40-9 | C21H20O6 | 368.38 | Anhydroicaritin; 3,5,7-Trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
Idebenone | 58186-27-9 | C19H30O5 | 338.44 | Idebenone; CV 2619; CV-2619; CV2619; Catena, Raxone, Sovrima |
IDE-2 | 1136466-93-7 | C12H20N2O3 | 240.3 | |
IDE-1 | 1160927-48-9 | C15H18N2O5 | 306.31 | 7-[2-(2-Carboxybenzylidene)hydrazinyl]-7-oxoheptanoic acid; IDE1; IDE-1; IDE 1 |
Idazoxan hydrochloride | 79944-56-2 | C11H13ClN2O2 | 240.69 | RX 781094; 2-(1,4-Benzodioxan-2-yl)-2-imidazoline hydrochloride; 2-(2,3-Dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole Hydrochloride; (+/-)-Idazoxan Monohydrochloride |
Idasanutlin | 1229705-06-9 | C31H29Cl2F2N3O4 | 616.487 | RG7388; RG 7388; RG-7388; RO5503781; RO-5503781; RO 5503781 |
Idarubicinone | 60660-75-5 | C20H16O7 | 368.3 | (7S,9S)-9-acetyl-6,7,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione; 4-Demethoxydaunomycinone |
Idarubicin Hydrochloride | 57852-57-0 | C26H27NO9.HCl | 533.95 | 4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl |
ID-8 | 147591-46-6 | C16H14N2O4 | 298.29 | ID 8; 1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol |
Icterogenin | 561-47-7 | C35H52O6 | 568.795 | |
iCRT5 | 18623-44-4 | C16H17NO5S2 | 367.44 | 4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid; 4-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid; EN300-00774; AC1Q49FJ |
iCRT3 | 901751-47-1 | C23H26N2O2S | 394.533 | 2-[[2-(4-Ethylphenyl)-5-methyl-1,3-oxazol-4-yl]methylsulfanyl]-N-phenethylacetamide |
iCRT 14 | 677331-12-3 | C21H17N3O2S | 375.44 | CHEMBL3589010; STK155594; 5-[[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedione |
Icotinib hydrochloride | 1204313-51-8 | C22H22ClN3O4 | 427.885 | Icotinib HCl; BPI-2009 |
Icotinib | 610798-31-7 | C22H21N3O4 | 391.42 | BPI-2009H |
Icosanamide | 51360-63-5 | C20H41NO | 311.554 | Eicosanamide; Arachamide |
Icosanal | 2400-66-0 | C20H40O | 296.531 g/mol | Icosanal;Eicosanal;2400-66-0;FWBUWJHWAKTPHI-UHFFFAOYSA-N;EINECS219-275-5;AI3-24217 |
icosan-1-amine | 10525-37-8 | C20H43N | 297.562 g/mol | |
Icopezil maleate | 145815-98-1 | C27H29N3O6 | 491.54 | UNII-1P15W0SPEN; Icopezil maleate [USAN]; Icopezil maleate (USAN); 145815-98-1; CHEMBL329012; CP 118954-11 |
Icofungipen | 198022-65-0 | C7H11NO2 | 141.167 | (1R,2S)-2-amino-4-methylidenecyclopentane-1-carboxylic acid; Cyclopentanecarboxylic acid, 2-amino-4-methylene-, (1R,2S)- (9CI); Icofungipen; PLD 118; PLD118; PLD-118; BAY 10-8888; BAY 108888; BAY108888 |
Iclaprim | 192314-93-5 | C19H22N4O3 | 354.41 | 5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4- diamine; AR 100 |
Icilin | 36945-98-9 | C16H13N3O4 | 311.29 | AG 3-5; 3,4-Dihydro-3-(2-hydroxyphenyl)-6-(3-nitrophenyl)-(1H)-pyrimidin-2-one; 3,6-dihydro-1-(2-hydroxyphenyl)-4-(3-nitrophenyl)-2(1H)-pyrimidinone; |
ICI-198615 | 104448-53-5 | C28H28N4O6S | 548.61 | [1-[[2-Methoxy-4-[[(phenylsulfonyl)amino]carbonyl]phenyl]methyl]-1H-indazol-6-yl]carbamic acid cyclopentyl ester;Cyclopentyl N-[1-[[4-(benzenesulfonylcarbamoyl)-2-methoxyphenyl]methyl]indazol-6-yl]carbamate;ICI198615;ZM198615;ZM-198615 |
ICI141292 | 86880-51-5 | C20H23N3O4 | 369.41 | N-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-2-(4-hydroxyphenyl)acetamide; epanolol; ICI 141,292; ICI 141292; ICI-141,292; N-(2-((3-(2-cyanophenoxy)-2-hydroxypropyl)amino)ethyl)-4-hydroxyphenylacetamide; Visacor |
ICI-118551 HCl | 72795-19-8 | C17H28ClNO2 | 313.866 | ICI-118551; ICI118551; ICI 118551; ICI-118,551; ICI118,551; ICI 118,551. |
ICI 89406 | 53671-71-9 | C19H22N4O3 | 354.41 | N-[2-[3-(2-Cyanophenoxy)-2-hydroxypropylamino]ethyl]-N'-phenylurea |
ICI 63197 | 27277-00-5 | C9H13N5O | 207.23 | 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one; 2-Amino-4,5-dihydro-6-methyl-4-propyl-s-triazolo[1,5-a]pyrimidin-5-one |
ICI 216140 | 124001-41-8 | C45H65N13O8 | 916.1 | |
ICI 211965 | 129424-08-4 | C24H23NO2S | 389.52 | 1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether |
ICI 204,448 hydrochloride | 121264-04-8 | C23H27Cl3N2O4 | 501.84 | (±)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride; (RS)-[3-[1-[[(3,4-Dichlorophenyl)acetyl]methylamino]-2-(1-pyrrolidinyl)ethyl]phenoxy]acetic acid hydrochloride |
ICI 199,441 hydrochloride | 115199-84-3 | C21H25Cl3N2O | 427.80 | 3,4-Dichloro-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]-benzeneacetamide Monohydrochloride; (S)-3,4-Dichloro-N-methyl-N-[1-phenyl-2-(1-pyrrolidinyl)ethyl]-benzeneacetamide Monohydrochloride; 2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-py |
ICI 192,605 | 117621-64-4 | C22H23ClO5 | 402.87 | (4Z)-rel-, 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid; 4-Hexenoic acid, 6-[(2R,4R,5S)-2-(2-chlorophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]-; 4-(Z)-6-(2-o-Chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl)hexenoic aci |
ICI 185,282 | 106393-80-0 | C18H21F3O5 | 374.36 | 5-(Z)-7-(4-o-Hydroxyphenyl-2-trifluoromethyl-1,3 dioxan-cis-5-yl)heptenoic acid |
ICI 174,864 | 89352-67-0 | C38H53N5O7 | 691.87 | N,N-Di-2-propen-1-yl-L-tyrosyl-2-methylalanyl-L-phenylalanyl-L-leucine; NIH 10893; N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine; L-Leucine, N-(N-(N-(N,N-di-2-propenyl-L-tyrosyl)-2-methylalanyl)-L-phenylalanyl)-; N,N-Diallyl-Tyr-aib- |
ICI 162,846 | 84545-30-2 | C11H17F3N6O | 306.29 | N-[1-(4-Carboxamidobutyl)-1H-pyrazol-3-yl)]-N'-(2,2,2-trifluoroethyl)guanidine; 3-[[Imino[(2,2,2-trifluoroethyl)amino]methyl]amino]-1H-pyrazole-1-pentanamide |
ICI 118551 hydrochloride | 72795-01-8 | C17H27NO2.HCl | 313.86 | (±)-erythro-(S*,S*)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride; (2R,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol;hydrochloride; |
ICG-001 | 780757-88-2 | C33H32N4O4 | 548.63 | ICG 001; (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-8-(naphthalen-1-ylmethyl)-4,7-dioxo-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide |
ICEC-0942 | 1805833-75-3 | C22H30N6O | 394.52 | CT7001 |
I-CBP112 hydrochloride | 2147701-33-3 | C27H36N2O5·HCl | 505.1 | 1-[7-(3,4-dimethoxyphenyl)-9-[[(3S)-1-methylpiperidin-3-yl]methoxy]-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]propan-1-one hydrochloride |
I-CBP 112 | 1640282-31-0 | C27H36N2O5 | 468.59 | 1-[7-(3,4-Dimethoxyphenyl)-9-[[(3S)-1-methylpiperidin-3-yl]methoxy]-2,3,4,5-tetrahydro-1,4-benzoxazepin-4-yl]propan-1-one |
Icatibant acetate | 138614-30-9 | C59H89N19O13S | 1304.541 | HOE 140 Acetate |
Icatibant | 130308-48-4 | C59H89N19O13S | 1304.52 | HOE140; HOE 140; HOE-140 |
Icariside I hydrate | 128988-55-6 | C27H32O12 | 548.5 | Maohuoside A; Pletypetaloside; 3,5-dihydroxy-8-(3-hydroxy-3-methylbutyl)-2-(4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one |
Icariside I | 56725-99-6 | C27H30O11 | Icariin I | |
Icariside F2 | 115009-57-9 | C18H26O10 | 402.396 | Benzyl Acuminose |
Icariin peracetate | 56692-02-5 | C49H56O23 | 1012.96 | ICARRIN; 5-(Acetyloxy)-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-7-[(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy]-3-[(2,3,4-tri-O-acetyl-6-deoxy-alpha-L-mannopyranosyl)oxy]-4H-1-benzopyran-4-one; Icariin peracetate |
Icariin | 489-32-7 | C33H40O15 | 676.66 | 3-[(6-Deoxy-a-L-mannopyranosyl)oxy]-7-b-D-glucopyranosyloxy-5-hydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
ICA-121431 | 313254-51-2 | C23H19N3O3S2 | 449.54 | 2,2-diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide 2,2-diphenyl-N-(4-(N-thiazol-2-ylsulfamoyl)phenyl)acetamide ICA-121431 |
ICA-069673 | 582323-16-8 | C11H6ClF2N3O | 269.63 | N-(2-chloropyrimidin-5-yl)-3,4-difluorobenzamide; ICA-069673; ICA 069673; ICA069673 |
ICA 110381 | 325457-99-6 | C12H8Cl2N2O | 267.11 | 4-Chloro-N-(6-chloro-3-pyridinyl)benzamide |
IC87201 | 866927-10-8 | C13H10Cl2N4O | 309.15 | 2-[(2H-benzotriazol-5-ylamino)methyl]-4,6-dichlorophenol 2-((1H-benzo(d)(1,2,3)triazol-5-ylamino)methyl)-4,6-dichlorophenol IC 87201 IC-87201 IC87201 |
IC-87114 | 371242-69-2 | C22H19N7O | 397.442 | |
IC86621 | 404009-40-1 | C12H15NO3 | 221.256 | IC-86621; IC 86621; IC86621. |
Ibutilide Related Compound A | 100632-58-4 | C20H32N2O4S | 396.55 | N-Ethyl-N-heptyl-4-[(methylsulfonyl)amino]-gamma-oxo-benzenebutanamide; 1,4-Diketo Ibutilide; N-Ethyl-N-heptyl-4-(4-(MethylsulfonaMido)phenyl)-4-oxobutanaMide; N-Ethyl-N-heptyl-4-[(methylsulfonyl)amino]-gamma-oxo-benzenebutanamide |
Ibutilide fumarate | 122647-32-9 | (C20H36N2O3S)2.C4H4O4 | 885.23 | U-70226E; U 70226E; U70226E |
Ibutamoren Mesylate | 159752-10-0 | C28H40N4O8S2 | 624.77 | MK-677; Crescendo; MK 0677; MK-0677; MK0677 |
Ibutamoren | 159634-47-6 | C27H36N4O5S | 528.668 | Ibutamoren; L 163191; MK-0677; MK-677. |
Ibuproxam | 53648-05-8 | C13H19NO2 | 221.29546 | Ibuproxam; Ibudros; Ibuproxamum; n-hydroxy-2-(4-isobutylphenyl)propanamide; 53648-05-8; CHEMBL292707 |
IBUPROFENPICONOL | 112017-99-9 | C19H23NO2 | 297.396 | |
Ibuprofen-D3 | 121662-14-4 | C13H15O2D3 | 209.30 | 2-(4-Isobutyl phenyl)- 3,3,3-trideutero propionic acid |
Ibuprofen-13C-d3 | 1261394-40-4 | C13H15O2D3 | 210.29 | Ibuprofen-(methyl-13C,d3) |
IBUPROFEN SODIUM SALT | 31121-93-4 | C13H17NaO2 | 228.26 | ALPHA-METHYL-4-[2-METHYLPROPYL]BENZENEACETIC ACID SODIUM SALT; ALPHA-METHYL-4-(ISOBUTYL)PHENYLACETIC ACID SODIUM SALT; IBUPROFEN SODIUM SALT; alpha-methyl-4-(2-methylpropyl)-benzeneaceticacisodiumsalt; ibuprofensodium; p-isobutylhydratropicacidsodiumsalt |
Ibuprofen Related Compound (2,3-Dihydroxypropyl 2-(4-Isobutylphenyl)Propanoate) | 64622-21-5 | C16H24O4 | 280.37 | |
Ibuprofen Related Compound (1,3-Dihydroxyprop-2-yl 2-(4-Isobutylphenyl)Propanonate) | 124635-85-4 | C16H24O4 | 280.37 | |
Ibuprofen piconol | 64622-45-3 | C19H23NO2 | 297.4 | Pimeprofen; Staderm; Vesicum; pyridin-2-ylmethyl 2-[4-(2-methylpropyl)phenyl]propanoate |
Ibuprofen Impurity F | 65322-85-2 | C13H18O2 | 206.29 | 3-(p-Isobutylphenyl)propionic Acid; 4-(2-Methylpropyl)benzenepropanoic Acid; Benzenepropanoic acid, 4-(2-Methylpropyl)-; 3-(4-Isobutylphenyl)propionic acid |
Ibuprofen Impurity E | 38861-78-8 | C12H16O | 176.26 | 4'-Isobutylacetophenone; 1-[4-(2-Methylpropyl)phenyl]ethanone; 1-Acetyl-4-isobutylbenzene; 1-[4-(2-Methylpropyl)phenyl]ethanone; 4-(2-Methylpropyl)acetophenone; NSC 173015; p-Acetylisobutylbenzene; p-Isobutylacetophenone; p-Isobutylphenyl Methyl Ketone; 4 |
IACS-9571 | 1800477-30-8 | C32H42N4O8S | 642.77 | N-(6-(3-(4-(dimethylamino)butoxy)-5-propoxyphenoxy)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-3,4-dimethoxybenzenesulfonamide; IACS-9571; IACS 9571; IACS9571; IACS 009571-001-4 |
Ibiglustat | 1401090-53-6 | C20H24FN3O2S | 389.49 | GZ402671; SAR402671; SAR-402671; SAR 402671; Genz-682452-AA; Ibiglustat; GZ-452; Genz-682452;(3S)-1-azabicyclo[2.2.2]octan-3-yl N-{2-[2-(4-fluorophenyl)- 1,3-thiazol-4-yl]propan-2-yl}carbamate |
IACS-010759 | 1570496-34-2 | C25H25F3N6O4S | 562.57 | 5-(5-methyl-1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-1H-1,2,4-triazol-3-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole |
I2906 | 331963-29-2 | C25H37N3O4 | 443.58 | I 2906; I-2906 |
HX-752 | 7652-64-4 | C14H16N2O2 | 244.29 | HX-752; 1,1-Isophthaloyl-bis(2-methylaziridine) |
Hyaluronic acid | 9004-61-9 | (C14H21NO11)n | ||
Hypofluorousacid (8CI,9CI) | 14034-79-8 | FH O | 36.0057 | hypofluorousacid;Hypofluorousacid;14034-79-8;HOF;fluoranol;fluoroalcohol |
Hypocrellin C | 149457-83-0 | C30H24O9 | 528.5 | Shiraiachrome C |
Hypocrellin B | 123940-54-5 | C30H26O10 | 546.5 | |
Hypocrellin A | 77029-83-5 | C30H26O10 | 546.528 | |
hypochlorite | 14380-61-1 | ClO | 51.452 | |
hypobromous acid | 13517-11-8 | BrHO | 96.9113 g/mol | hypobromousacid; Hypobromousacid; HOBr; 13517-11-8; 14380-62-2; bromanol |
Hypericin | 548-04-9 | C30H16O8 | 504.45 | 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone;Hypericum red;Hipericina;Hypericine;Hyperizin;SGX301;SGX-301;1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione;Cyclo-Werol;Cyclosan;Hyperflav |
Hyperforin dicyclohexylammonium salt | 238074-03-8 | C35H52O4·C12H23N | 718.1 | Hyp-DCHA; Hyperforin-DCHA; Hyperforin DCHA |
Hypaphorine | 487-58-1 | 246.3 | Lenticin; Tryptophan betaine; Glyyunnanenine | |
Hypaconine | 63238-68-6 | C24H39NO8 | Benzoylhypacoitine; (1alpha,6alpha,14alpha,15alpha,16beta)-1,6,16-Trimethoxy-4-(methoxymethyl)-20-methylaconitane-8,13,14,15-tetrol; 3-Deoxymesaconine | |
Hyoscyamine sulphate | 620-61-1 | 2C17H23NO3.H2O4S | 676.822 | Levsin sulfate; Hyoscyamine sulfate |
Hydroxypioglitazone (M-IV) hydrochloride | 146062-46-6 | C19H20N2O4S.HCl | 408.9 | 1-Hydroxy Pioglitazone Hydrochloride; 5-[4-[2-[5-(1-hydroxyethyl)-2-pyridyl]ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride |
Hydroxythiohomosildenafil | 479073-82-0 | C23H32N6O4S2 | 520.67 | 5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidine-7-thione; 4-[[3-(4,7-Dihydro-1-methyl-3-propyl-7-thioxo-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-1-piperazineeth |
Methscopolamine bromide | 155-41-9 | C18H24BrNO4 | 398.29 | N-methyl scopolamine bromide; scopolamine methyl bromide; DD-234; DD 234; DD234; Pamine |
Hyodeoxycholic acid sodium salt | 10421-49-5 | C24H39NaO4 | 414.55 | SODIUM HYODEOXYCHOLATE; HYODEOXYCHOLIC ACID SODIUM SALT; 3ALPHA,6ALPHA-DIHYDROXY-5BETA-CHOLAN-24-OIC ACID SODIUM SALT; 5BETA-CHOLAN-24-OIC ACID-3ALPHA,6ALPHA-DIOL SODIUM SALT; 3,6-dihydroxy-,monosodiumsalt,(3alpha,5beta,6alpha)-cholan-24-oicaci; hyodeoxyc |
Hyodeoxycholic acid (HDCA) | 83-49-8 | C24H40O4 | 392.57 | |
Hydroxythio Vardenafil | 912576-30-8 | C23H32N6O4S2 | 520.68 | 2-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazine-4(1H)-thione; 4-[[3-(1,4-Dihydro-5-methyl-7-propyl-4-thioxoimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-1-piperazineethanol |
Hydroxyterbinafine b-D-glucuronide | 99473-12-8 | C27H33NO7 | 483.57 | |
hydroxyoctadecanoic acid, monoester with glycerol | 1323-42-8 | C21H42O5 | 374.558 | GLYCERYL MONO-12-HYDROXYSTEARATE; GLYCEROL MONOHYDROXYSTEARATE; hydroxyoctadecanoic acid, monoester with glycerol; GLYCERYL HYDROXYSTEARATE; Octadecanoic acid, hydroxy-, monoester with 1,2,3-propanetriol |
HYDROXYMETHYLSTYRENE | 30584-69-1 | C27H30O3 | 402.53 | VINYLBENZYL ALCOHOL; HYDROXYMETHYLSTYRENE; ar-vinylbenzyl alcohol; Vinylbenzyl alcohol, mixture of isomers; Vinylbenzylalcohol90%mixtureofisomersstabilized; Vinylbenzyl alcohol, mixture of isomers, stabilized, 90%; Benzenemethanol, ar-ethenyl |
Hydroxymethylphenylphosphinic acid | 61451-78-3 | C7H9O3P | 172.12 | |
Hydroxymethyldiphenylsilane | 778-25-6 | C13H14OSi | 214.33 | Hydroxymethyldiphenylsilane; Methyldiphenylsilanol |
Hydroxymethylclenbuterol hydrochloride | 37162-89-3 | C12H19Cl3N2O2 | 329.653 | 2-[2-(4-Amino-3,5-dichlorophenyl)-2-hydroxyethylamino]-2-methylpropan-1-ol hydrochloride |
Hydroxyhomo Sildenafil | 139755-85-4 | C23H32N6O5S | 504.61 | 5-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; Lodenafil |
Hydroxyhexamide | 3168-01-2 | C15H22N2O4S | 326.41 | HYDROXYHEXAMIDE; AC1L2C6O; CHEMBL2105052; HY-B1103 |
Hydroxygenkwanin | 20243-59-8 | C16H12O6 | 300.3 | 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one;2-(3,4-Dihydroxyphenyl)-7-methoxy-5-hydroxy-4H-1-benzopyran-4-one;3',4',5-Trihydroxy-7-methoxyflavone; |
Hydroxyflubendazole | 82050-12-2 | {5-[(4-Fluoro-phenyl)- hydroxy-methyl]-1H- benzoimidazol-2-yl}- carbamic acid methyl ester | ||
Hydroxyfasudil Hydrochloride | 155558-32-0 | C14H18ClN3O3S | 343.826 | HA 1100 hydrochloride; 5-(1,4-diazepan-1-ylsulfonyl)-2-[H]-isoquinolin-1-one hydrochloride; 1-[(1,2-Dihydro-1-oxo-5-isoquinolinyl)sulfonyl]hexahydro-1H-1,4-diazepine hydrochloride |
Hydroxyfasudil | 105628-72-6 | C14H17N3O3S | 307.37 | 5-(1,4-Diazepane-1-sulfonyl)-1,2-dihydroisoquinolin-1-one;1-[(1,2-Dihydro-1-oxo-5-isoquinolinyl)sulfonyl]hexahydro-1H-1,4-diazepine;Hydroxyfasudil |
Hydroxyevodiamine | 1238-43-3 | C19H17N3O2 | 13b-Hydroxy-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one | |
Hydroxyethylamino-di (methylene phosphonic acid) | 5995-42-6 | C4H13NO7P2 | 249.096042 | [[(2-hydroxyethyl)imino]bis(methylene)]bisphosphonic acid; Phosphonic acid, (2-hydroxyethyl)iminobis(methylene)bis-; ethanolaminedi(methylenephosphonic acid); 2-[Bis(phosphonomethyl)amino]ethanol; 2-Hydroxyethylbis(phosphonomethyl)amine; 2-Hydroxyethylimi |
Hydroxy tolbutamide d9 | 1185112-19-9 | C12H9D9N2O4S | 295.40 | N-(Butylamnocarbonyl)-4-hydroxymethylbenzenesulfonamide-d9; Hydroxytolbutamide-d9; Hydroxymethylcarbutamide-d9; 1-Butyl-3-(p-hydroxymethylphenyl)sulfonylurea-d9 |
Hydroxy tolbutamide | 5719-85-7 | C12H18N2O4S | 286.35 | N-(Butylamnocarbonyl)-4-hydroxymethylbenzenesulfonamide; 1-Butyl-3-(p-hydroxymethylphenyl)sulfonylurea; Hydroxytolbutamide; Hydroxymethylcarbutamide |
Hydroxy pioglitazone (M-VII) b-D-glucuronide | 625853-75-0 | C25H28N2O10S | 548.56 | 2-[6-[2-[4-[(2,4-Dioxo-5-thiazolidinyl)methyl]phenoxy]ethyl]-3-pyridinyl]ethyl b-D-glucopyranosiduronic acid |
Hydroxy Tipelukast | 1027597-04-1 | C29H40O7S | 532.70 | 4-(3-(3-((4-Acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-6-(1-hydroxyethyl)-2-propylphenoxy)butanoate |
Hydroxy Tetrabenazine | 3466-75-9 | C19H29NO3 | 319.45 | rac-(2,3)-Dihydro Tetrabenazine [Cis/Trans Mixture]; Mixture of cis and trans Isomers |
Hydroxy Sulfentrazone | 134390-99-1 | C11H10Cl2F2N4O4S | 403.19 | |
Hydroxy Pioglitazone-d4 (M-IV) (deuterated) | 1188263-49-1 | C19H16D4N2O4S | 376.47 | 5-[[4-[2-[5-(1-Hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione-d4 |
Hydroxy Pioglitazone-d4 (M-II) (deuterated) | 101931-00-4 | C19H16N2O4SD4 | 376.47 | |
Hydroxy Pioglitazone (M-VII) | 625853-72-7 | C19H20N2O4S | 372.45 | |
Hydroxy Pioglitazone | 146062-44-4 | C19H20N2O4S | 372.44 | Hydroxypioglitazone; Leriglitazone; 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
Hydroxy Pentoxifylline-d6 | 1185995-26-9 | C13H14N4O3D6 | 286.37 | (+/-)-Lisofylline-d6; 3,7-Dihydro-1-(5-hydroxyhexyl)-3,7-(dimethyl-d6)-1H-purine-2,6-dione; 1-(5-Hydroxyhexyl)theobromine-d6; (+/-)-1-(5-Hydroxyhexyl)-3,7-(dimethyl-d6) xanthine; BL 194-d6; Pentoxifylline-d6 Alcohol |
Hydroxy pentoxifylline | 6493-06-7 | C13H20N4O3 | 280.33 | (±)-Lisofylline; BL 194; CT-1501R; LSF; 3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6-dione |
Hydroxy Metronidazole | 4812-40-2 | C6H9N3O4 | 187.16 | 2-(Hydroxymethyl)-5-nitro-1H-imidazole-1-ethanol; Metronidazole-OH; 1-(2-Hydroxyethyl)-2-(hydroxymethyl)-5-nitroimidazole; Hydroxymetronidazole; |
Hydroxy Melphalan | 61733-01-5 | C13H19ClN2O3 | 286.75 | 4-[(2-Chloroethyl)(2-hydroxyethyl)amino]-L-phenylalanine; Melphalan EP Impurity D |
Hydroxy Medetomidine | 128366-50-7 | C13H16N2O | 216.28 | 3-[1-(1H-Imidazol-5-yl)ethyl]-2-methylbenzenemethanol |
Hydroxy Loxoprofen-14C | 88378-21-6 | C15H20O3 | 250.32 | |
Hydroxy Gliclazide | 87368-00-1 | C15H21N3O4S | 339.42 | N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)benzenesulfonamide; BenzenesulfonaMide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)aMino]carbonyl]-4-(hydroxyMethyl)- |
HYDRAULIC FLUID | 64742-54-7 | 0 | distillates(petroleum),hydrotreated(mild)heavyparaffinic; distillates(petroleum),hydrotreated(severe)heavyparaffinic; distillates(petroleum),hydrotreatedheavyparaffinic; Distillates,petroleum,hydrotreatedheavyparaffinic; emulsifiableoil; emulsifiableoil,h | |
Hydrochlorothiazide-13C-d2 | 1190006-03-1 | C6H6ClN3O4S2[13C]D2 | 300.74 | 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-13C,d2-7-sulfonamide 1,1-Dioxide; Aquarius-13C,d2; Bremil-13C,d2; Cidrex-13C,d2; Dichlotride-13C,d2; Diurizid-13C,d2; Drenol-13C,d2; Hidrochlortiazid-13C,d2; Hydrex-13C,d2; Oretic-13C,d2; Pantemon-13C,d2; Thi |
Hydrochlorothiazide Related Compound (N-[(2-Aminophenyl)sulfonyl] Acetamide) | 75304-18-6 | C8H10N2O3S | 214.24 | |
Hydrochlorothiazide Related Compound (N'-(2-Acetyl-sulfamoyl-4-chloro-phenyl) Acetamide) | 90794-87-9 | C10H11ClN2O4S | 290.73 | |
Hydrochlorothiazide Impurity C | 402824-96-8 | C15H16Cl2N6O8S4 | 607.49 | N-[[7-(Aminosulfonyl)-6-chloro-2,3-dihydro-1,1-dioxo-4H-1,2,4-benzothiadiazin-4-yl]methyl]-6-chloro-3,4-dihydro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide ; HCTZ-CH2-HCTZ; 6-Chloro-4-({[(6-Chloro-1,1-Dioxido-3,4-Dihydro-2H-1,2,4-Benzothiadiazin-7-Y |
Hydrochloric acid-d,compd. with guanidine-d5 (1:1) (9CI) | 108694-93-5 | CD5 N3 . Cl D | 101.57 | GUANIDINE-D5 DCL; GUANIDINE-D5 DEUTERIOCHLORIDE; GUANIDINE-D5 DEUTERIUM CHLORIDE; GUANIDINE-D5 DEUTERIOCHLORIDE, 98 ATOM % D; guanidine-d5deuterochloride; Guanidine-D5 CL |
Hydrazinoacetic acid | 14150-64-2 | C2H6N2O2 | 90.0812 g/mol | |
Hydralazine HCl | 304-20-1 | C8H8N4.HCl | 196.64 | Hydralazine hydrochloride |
hydralazine | 86-54-4 | C8H8N4 | 160.18 | |
hydracarbazine | 3614-47-9 | C5H7N5O | 153.144 | 6-hydrazinylpyridazine-3-carboxamide |
Hydnocarpin | 51419-48-8 | C25H20O9 | 464.4 | (Rac)-Hydnocarpin |
Hydantoin-4,5-13C2, 15N | 1189495-02-0 | CH4NO2[13C]2[15N] | 103.05 | 2,4-Imidazolidinedione-4,5-13C2,1-15N; Imidazole-2,4(3H,5H)-dione-4,5-13C2,1-15N; Glycolylurea-4,5-13C2,1-15N; NSC 9226-4,5-13C2,1-15N |
Hydantoin | 461-72-3 | C3H4N2O2 | 100.08 | 2,4-Imidazolidinedione; Imidazole-2,4(3H,5H)-dione; Glycolylurea; NSC 9226 |
Hycanthone | 3105-97-3 | C20H24N2O2S | 356.484 | Etrenol. |
Hybridaphniphylline B | 1467083-09-5 | C37H47NO11 | 681.78 | |
Hybridaphniphylline A | 1467083-07-3 | C37H47NO11 | 681.77 | (1S,1aR,3S,3aS,3a1S,5aS,7aR,7bR,9aS,12S,13R,14aR,14bS,14cR)-4-(hydroxymethyl)-12,14b-dimethyl-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,1a,3,3a,3a1,5a,8,9,9a,10,11,12,13,14,14a,14b,15,16-o |
Hybrid N-Glycan | 84182-21-8 | C62H104N4O46 | 1641.49 | Hybrid-type, bisected, N-linked glycan; M5A1B N-Glycan; Mannopentaose-di-(N-acetylglucosamine), N-acetylglucosaminyl-bisecting-N-acetylglucosaminyl; GlcNAc(GlcNAc)Man5(GlcNAc)2 |
Hybendazole hydrochloride | 37975-24-9 | C14H13ClN2O | 260.72 | DL-2-(alpha-Hydroxybenzyl)benzimidazole hydrochloride; |
Hyaluronidase(sheep testis isoenzyme) | 488712-31-8 | |||
Hyaluronidase from Streptomyces hyalurolyticus | 37259-53-3 | |||
Hyaluronicacidpotassiumsalt | 31799-91-4 | |||
Hyaluronic acid,sodium salt,mixt. with 1,2,3-propanetriol | 220476-17-5 | |||
Hyaluronic acid tetrasaccharide ammonium salt | 634181-32-1 | C28H42N2O22 xNH3 | 758.63 (free acid basis) | |
Hyaluronic acid tetrasaccharide | 57282-61-8 | C28H44N2O23 | 776.65 | Hyaluronate tetrasaccharide; Hyaluronic acid tetramer |
Hyaluronic acid hexasaccharide ammonium salt | 73603-40-4 | C42H65N3O34 | 1155.97 | Hyaluronic acid oligosaccharide dp6; Hyaluronate hexasaccharide |
Hyaluronic acid disaccharide sodium salt | 149368-06-9 | C14H20NNaO11 | 401.30 | di-HA sodium salt |
Hyaluronateglycanohydrolase | 9001-54-1 | |||
HX-603 | 259228-72-3 | C31H34N2O2 | 466.625 | 4-(7,7,10,10-tetramethyl-5-propyl-8,9-dihydronaphtho[2,3-b][1,5]benzodiazepin-12-yl)benzoic acid; HX-603; HX 603; HX603 |
HX 630 | 188844-52-2 | C28H27NO2S | 441.58 | 4-(7,8,9,10-Tetrahydro-7,7,10,10-tetramethylbenzo[b]naphtho[2,3-f][1,4]thiazepin-12-yl-benzoic acid |
HX 531 | 188844-34-0 | C29H29N3O4 | 483.56 | 4-(7,8,9,10-Tetrahydro-5,7,7,10.10-pentamethyl-2-nitro-5H-benzo[b]naphtho[2,3-e][1,4]-diazepin-12-yl)-benzoic acid |
hVEGF-IN-1 | 1637443-98-1 | C34H43N7O2 | 581.75 | 1-Piperazinepropanamide, N-[2-[4-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-2-quinazolinyl]phenyl]-4-methyl |
HUPERZINE | 116-28-9 | C15H18N2O | 242.32 | HUPERIZNE; HUPERZINE; Huperzia Serrata Extract; selagnine |
Humulone | 26472-41-3 | C21H30O5 | 362.47 | (6S)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one |
Humulene epoxide II | 19888-34-7 | C15H24O | ||
Human Choroinic Gonadotrophin | 9002-61-3 | C17H28 | 232.40422 | HCG; HCG, HUMAN; HCG, INTACT; HUMAN CHORIONIC GONADOTROPHIN; HUMAN CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, HUMAN URINE; CHORIONIC GONADOTROPIN HORSE; CHORIONIC GONADOTROPIN HUMAN |
HUHS015 | 1453097-13-6 | C19H18N4O | 318.37242 | HUHS015; HUHS 015; HUHS-015 |
HU 210 | 112830-95-2 | C25H38O3 | 386.57 | HU-210; HU210; (6aR)-trans-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol |
H-TYR-NCA | 3415-08-5 | C10H9NO4 | 207.18276;g/mol | (4S)-4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidine-2,5-dione; (S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione; 3415-08-5; H-TYR-NCA; N-Carboxy-L-tyrosineanhydride; CTK8C5018 |
H-TYR-LYS-OH | 54925-88-1 | C15H23N3O4 | 309.36 | L-TYR-LYS; H-TYR-LYS-OH |
H-TYR-LEU-NH2 HCL | 281213-44-3 | C15H24ClN3O3 | 329.82 | H-TYR-LEU-NH2 HCL |
H-Tyr(3,5-F2)-OH | 73246-30-7 | C9H9F2NO3 | 217.1694664 | H-Tyr(3,5-F2)-OH |
HTS01037 | 682741-29-3 | C14H11NO5S2 | 337.37 | 4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid; (E)-4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid; 4-{[2-(methoxycarbonyl)-5-(2-thienyl)-3-thienyl]amino}-4-oxo-2-butenoic acid |
HTMT dimaleate | 195867-54-0 | C19H25F3N4O.2C4H4O4 | 614.57 | 6-[2-(4-Imidazolyl)ethylamino]-N-(4-trifluoromethylphenyl)heptanecarboxamide dimaleate; Histamine trifluoromethyl toluidide |
HO-3867 | 1172133-28-6 | C28H30F2N2O2 | 464.557 | HO 3867; EX-A2319; (3E,5E)-3,5-bis[(4-fluorophenyl)methylidene]-1-[(1-hydroxy-2,2,5,5-tetramethylpyrrol-3-yl)methyl]piperidin-4-one |
HNMPA-(AM)3 | 120944-03-8 | C20H23O10P | 454.4 | Hydroxy-2-naphthalenylmethylphosphonic acid trisacetoxymethyl ester |
HNMPA | 132541-52-7 | C11H11O4P | 238.2 | Hydroxy-2-naphthalenylmethyl phosphonic acid |
HNHA | 926908-04-5 | C17H21NO2S | 303.4 | Histone Deacetylase Inhibitor VI; N-hydroxy-7-naphthalen-2-ylsulfanylheptanamide |
HNGF6A | 1093111-54-6 | C112H198N34O31S2 | 2581.13 | |
HMR 1556 | 223749-46-0 | C17H24F3NO5S | 411.44 | N-[(3R,4S)-3,4-Dihydro-3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)-2H-1-benzopyran-4-yl]-N-methylmetanesulfonamide |
HMR 1098 | 261717-22-0 | C19H21ClN3NaO5S2 | 493.96 | 5-chloro-2-methoxy-n-[2-[4-methoxy-3-(3-methylthioureidosulfonyl)phenyl]ethyl]benzamide sodium salt |
HMR 1031 | 479203-71-9 | C35H41N5O6 | 627.73 | Rnm7wqo98Y; (3S)-3-[[(2S)-2-[4,4-dimethyl-3-[[4-[(2-methylphenyl)carbamoylamino]phenyl]methyl]-2,5-dioxoimidazolidin-1-yl]-4-methylpentanoyl]amino]-3-phenylpropanoic acid |
HMN-214 | 173529-46-9 | C22H20N2O5S | 424.471 | HMN-214; HMN 214 |
HMN-176 | 173529-10-7 | C20H18N2O4S | 382.434 | HMN-176; HMN 176; HMN176. |
HMN-154 | 173528-92-2 | C20H18N2O3S | 366.43 | 4-methoxy-N-[2-[(E)-2-pyridin-4-ylethenyl]phenyl]benzenesulfonamide; (E)-4-(2-(2-p-methoxy-benzene-sulfonamide) phenyl)(ethenyl ) pyridine; HMN 154; HMN-154 |
HMMNI-D3 | 1015855-78-3 | 2-Hydroxymethyl-1- methyl-D3-5-nitro-1H- imidazole | ||
HMMNI | 936-05-0 | C5H7N3O3 | 157.1 | 2-Hydroxymethyl-1-methyl-5-nitro-1H-imidazole; (1-Methyl-5-nitroimidazol-2-yl)methanol |
HLCL61 | 586395-74-6 | C23H24N2O | 344.19 | HLCL-61;9-Ethyl-N-[(2-methoxyphenyl)methyl]-9H-carbazole-3-methanamine;1-(9-Ethyl-9H-carbazol-3-yl)-N-(2-methoxybenzyl)methanamine |
HL 010183 | 1429218-03-0 | C14H20N6.HCl | 308.81 | |
HKI 357 | 848133-17-5 | C31H29ClFN5O3 | 574.05 | (2E)-N-[[4-[[(3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide |
HJC0350 | 885434-70-8 | C15H19NO2S | 277.38 | |
HJC0197 | 1383539-73-8 | C19H21N3OS | 339.45 | 4-cyclopentyl-2-((2,5-dimethylbenzyl)thio)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile |
HJC0152 hydrochloride | 1420290-99-8 | C15H14Cl3N3O4 | 406.644 | 2-(2-aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide hydrochloride |